From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America

Abstract

The past two decades have witnessed many advances in the prevention, treatment, and control of diabetes mellitus (DM) and its complications. Increased screening has led to a greater recognition of type 2 diabetes mellitus (type 2 DM) and prediabetes; however, Hispanics/Latinos, the largest minority group in the US, have not fully benefited from these advances. The Hispanic/Latino population is highly diverse in ancestries, birth places, cultures, languages, and socioeconomic backgrounds, and it populates most of the Western Hemisphere. In the US, the prevalence of DM varies among Hispanic/Latino heritage groups, being higher among Mexicans, Puerto Ricans, and Dominicans, and lower among South Americans. The risk and prevalence of diabetes among Hispanics/Latinos are significantly higher than in non-Hispanic Whites, and nearly 40% of Hispanics/Latinos with diabetes have not been formally diagnosed. Despite these striking facts, the representation of Hispanics/Latinos in pharmacological and non-pharmacological clinical trials has been suboptimal, while the prevalence of diabetes in these populations continues to rise. This review will focus on the epidemiology, etiology and prevention of type 2 DM in populations of Latin American origin. We will set the stage by defining the terms Hispanic, Latino, and Latin American, explaining the challenges identifying Hispanics/Latinos in the scientific literature and databases, describing the epidemiology of diabetes—including type 2 DM and gestational diabetes mellitus (GDM)—and cardiovascular risk factors in Hispanics/Latinos in the US and Latin America, and discussing trends, and commonalities and differences across studies and populations, including methodology to ascertain diabetes. We will discuss studies on mechanisms of disease, and research on prevention of type 2 DM in Hispanics/Latinos, including women with GDM, youth and adults; and finalize with a discussion on lessons learned and opportunities to enhance research, and, consequently, clinical care oriented toward preventing type 2 DM in Hispanics/Latinos in the US and Latin America.

Introduction

Poverty is the best cure for diabetes.

La pobreza es el mejor remedio contra la diabetes.

-Gabriel García Márquez (1)

Diabetes mellitus (DM) has been documented in the medical history of some Latin American countries since the late 1800s and early 1900s (2, 3). Although not a common disease at that time, type 1 DM was highlighted by medical societies in the Americas due to its dramatic presentation and fast clinical deterioration. In contrast, type 2 diabetes mellitus (type 2 DM) and its long-term complications only gained attention in the mid-twentieth century (2, 3). Over the next decades, type 2 DM would become recognized not just as a common chronic disease but also as one of the leading causes of death worldwide (4).

Why Is It Important to Understand Type 2 Diabetes in Hispanics/Latinos in the US and in Latin Americans?

Hispanics/Latinos in the US mainland constitute 17.6% of the population (5), and are the largest US minority group. It is projected that by year 2060, 29% of the US population will be of Hispanic/Latino descent (6). Compared to other US populations, the Hispanic/Latino population is younger, with nearly half of the US-born Hispanics/Latinos under age 18 (7). The prevalence of diabetes among Hispanics/Latinos in the US is 22.6%, and twice as high as that of non-Hispanic Whites (NHWs) (11.3%) (8). Diabetes has also become a leading cause of death in Latin America (9, 10).

Understanding type 2 DM among Hispanics/Latinos in the US and in Latin America poses several challenges. A long-standing assumption in the US is that Hispanics/Latinos are a demographically and ancestrally homogeneous group. However, as we will explain, Hispanics/Latinos are a highly heterogeneous group, and in fact, the prevalence of diabetes varies widely among different US Hispanic/Latino heritage groups (11–13). These differences in prevalence may be mediated by differences in ancestry, as well as differences in socioeconomic factors, cultural norms, dietary and physical activity (PA) patterns, and history of environmental exposures—among others—experienced in both the country of origin and the US.

As the foundations for precision and personalized medicine are built, it is clear that adequate prevention, diagnosis, and treatment of type 2 DM among Hispanics/Latinos in the US and in Latin America require deep understanding of its etiology, manifestations, and response to interventions across populations. Whereas diabetes has become a seemingly unavoidable outcome for many Hispanics/Latinos, it does not have to be so.

In this expert review, we will describe the epidemiology of type 2 DM and gestational diabetes mellitus (GDM) and traditional cardiovascular (CV) risk factors in Hispanics/Latinos in the US and Latin America based on selected studies. We will also discuss studies on the etiology of type 2 DM and GDM in Hispanic/Latino populations. Given the increasing prevalence of type 2 DM across the continent, and especially at younger ages, we considered imperative to focus on research dedicated to disease prevention in Hispanics/Latinos in the US and in Latin America. We will also highlight opportunities to enhance our knowledge through research within a holistic framework of multidimensional and transdisciplinary strategies; a framework that is also applicable to the clinical care of Hispanics/Latinos at risk of type 2 DM.

In this review, the term type 2 DM will be used throughout most of the text, and specially within the context of etiology and prevention. The term diabetes will be used within the context of epidemiology or when there is no distinction between type 1 and type 2 DM. As a reference, we have also included a list of acronyms and abbreviations used throughout the text (see Appendix).

Who Are the Hispanics/Latinos in the US and Latin Americans?

The Office of Management and Budget (OMB) and the US Census Bureau define Hispanic or Latino as “a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture regardless of race” (14). The racial and ethnic categories defined by the OMB have been challenged and are under revision (15). Figure 1 (16) illustrates where the largest Hispanic/Latino heritage groups live in the US and Puerto Rico based on the 2010 US Census.

Figure 1

16).

The terms Hispanic and Latino have different meanings in the US and abroad. Place of residence (17), ancestry group (18), or immigrant generation (18) may influence individuals’ preference for the term Hispanic, Latino, both, or neither. In this review, the term Hispanic/Latino refers to persons of Latin American descent who live in the US or in Latin America; that is, those who self-identify or trace their roots to countries in the Americas where Spanish, Portuguese, and French are the predominant languages (19, 20), excluding persons from Spain. The term Latin Americans refers to persons or populations in Latin America (19, 20).

Sociodemographic and Economic Characteristics of the Hispanic/Latino Population in the US and in Latin America

According to the US Census Bureau, Hispanics/Latinos have become the US largest minority group. This population increased nearly fourfold between 1980 and 2015, rising from 14.8 million (6.5%) to 56.6 million (17.6%) (21–23). The Hispanic/Latino population is projected to increase to 119 million, or nearly 29% of the population in 2060 (6), with growth attributed to high rates of immigration and fertility, and low overall mortality (24). In 2015, Hispanics/Latinos of Mexican origin were the largest Hispanic/Latino heritage group (63%), followed by Puerto Ricans (10%), Salvadorans (4%), Cubans (4%), and Dominicans (3%) (21).

As a group, Hispanics/Latinos are younger than other racial/ethnic groups in the US (median 28.7 years) and lag behind other groups in educational attainment (21) (Table 1). At 67%, the percentage of Hispanics/Latinos age 25 or older with a high school education or higher is significantly lower than that of NHWs (91.8%) (25). Poverty rates are significantly higher among Hispanics/Latinos (21.4%) than NHWs (9.1%) (26). In the US, unemployment among the population aged 16 years and older was highest among non-Hispanic Blacks (11.3%) and islander Puerto Ricans (8.4%), and lowest among NHWs (5%) and Hispanics/Latinos (4.9%). Islander Puerto Ricans continue to have higher poverty rates (46.1%) than other Hispanics/Latino groups in the US (22.6%), non-Hispanic Blacks (25.4%), and NHWs (10.4%) (21).

Hispanics/Latinos of any race are disproportionately affected by lack of health insurance compared to all other groups (27). While only approximately 10% of NHWs did not have healthcare insurance, nearly 20% of Hispanics/Latinos of any race lack health insurance. Within Hispanic/Latino subgroups, the percentage of uninsured individuals varied considerably, from 8.5% in Puerto Ricans to 28.2% in Central Americans (28, 29).

The population in Latin America and the Caribbean is projected to grow from 646 million currently to 784 million in 2050 (30). This population is relatively young with a median age of 29.2 years (31) (Table 2). Enrollment in secondary and tertiary education remains unequal in the region, ranging from 21.2% in Honduras to 88.6% in Chile. The percentage of the population classified as poor is highly variable, from 4.3% in Argentina to over 60% in Guatemala and Honduras.

Challenges in Identifying Hispanics/Latinos in US Government Reports and the Scientific Literature

Demographic Terminology

From the late 1800s and through most of the twentieth century, several terms have been used in the Census data and the medical literature to attempt to identify persons of Mexican origin, and later other Hispanics/Latinos (32, 33). Not surprisingly, the terms failed to accurately identify this elusive and complex mosaic of populations.

Through several modifications to the US Census since 1970 (33), blanket demographic terms such as “Hispanic” and “Latino” have been used to attempt to capture the specific cultural identities within the “Hispanic or Latino” populations. Despite the population’s diversity in virtually every element, this conglomerate of races, nationalities, and cultures is still regarded by many as a monolith.

Publications on US Hispanic/Latino Health

The earliest scientific reports on the health of any US Hispanic/Latino heritage group date from 1929 or earlier (34), and focused on tuberculosis in Mexican immigrants. Subsequent studies published from the 1950s to the 1970s addressed farm laborers’ health (35), folk medicine (36), sociological, psychiatric, and behavioral issues (37–42), hematologic and gastrointestinal disorders (43–46), infectious and tropical diseases (47–49), and women’s fertility (50), among other topics, and focused on Mexican immigrants, Puerto Rican migrants, and Puerto Rico. Thus, for most of the twentieth century, health-related studies in Hispanics/Latinos were isolated and did not address chronic diseases; furthermore, the manner in which Hispanics/Latinos were classified was inconsistent. Although the Framingham Heart Study was initiated in 1948 (51), and its first analyses on the incidence of cardiovascular disease (CVD) and associated risk factors were published between 1957 and 1959 (52, 53), the study of chronic diseases, in particular CV morbidity and mortality, in Hispanics/Latinos in the US did not start until the 1960s (54).

As we will describe, differences and similarities in the prevalence of diabetes and CV risk factors between Hispanics/Latinos and other racial/ethnic groups, and among Hispanic/Latino heritage groups would gradually be documented by various studies across the US. Understanding these differences and similarities could shed light on the interaction among various health determinants, and diabetes risk across populations. These differences and similarities are still being investigated.

Epidemiology of DM in Hispanics/Latinos in the US and Latin America

Diabetes in Hispanics/Latinos in the US

During the past three decades of the twentieth century, reports about chronic diseases—including diabetes—in the US Hispanic/Latino population started to be generated and disseminated through several epidemiological studies, including but not limited to the Puerto Rico Heart Health Program (54, 55), the Laredo Project (56), the San Antonio Heart Study (SAHS) (57, 58), the Hispanic Health and Nutrition Examination Survey (Hispanic HANES) (11, 59, 60), the San Luis Valley Diabetes Study (61), and later the National Health Interview Survey (NHIS) (28), the Behavioral Risk Factor Surveillance Survey (BRFSS) (62), and the National Health and Nutrition Examination Survey (NHANES) (63). However, most of the studies were cross-sectional and focused on one Hispanic/Latino heritage group or specific region of the US. Of these, the Hispanic HANES, conducted from 1982 to 1984, was the first epidemiological study to describe the prevalence of some chronic diseases, including diabetes, in the three largest Hispanic/Latino heritage groups at the time: Mexicans, Puerto Ricans, and Cubans (11, 59, 60). However, the Hispanic HANES was a one-time cross-sectional study. In 2006, the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a prospective study, was established to describe the prevalence of chronic diseases (especially CV and pulmonary), identify their risk or protective factors, and correlate them with future health outcomes in a cohort of US Hispanics/Latinos from diverse origins in a cohort of over 16,000 Hispanic/Latino adults from Central American, Cuban, Dominican, Mexican, Puerto Rican, and South American heritage living in San Diego, Chicago, Miami, and New York (64, 65).

There are important differences in these studies that make comparisons across them difficult: methodological variations in selection of study populations, diagnostic criteria to determine diabetes, lack of assessment to distinguish between type 1 and type 2 DM, proposed diagnostic cut points (66–68), and time-period of analysis. Further caution must be taken when interpreting data gathered across studies, because the lack of confirmatory testing of diagnostic criteria in some studies could result in an inaccurate estimate of the prevalence (66). Since some surveys restrict their sampling to specific geographic areas, generalizability of the findings to all Hispanics/Latinos living in the US or Latin America is reduced.

Table 3 lists selected US epidemiological studies focused on or that have included Hispanics/Latinos, and that have estimated diabetes prevalence (8, 11–13, 54–61, 64, 65, 69–95). An analysis of the 2011–2012 NHANES cycle showed that the unadjusted prevalence of total diabetes based on ADA criteria (2-h OGTT, FPG, or HbA1c) was 14.3% (9.1% for diagnosed diabetes and 5.2% for undiagnosed diabetes) and 38.0% for prediabetes (8). The prevalence of total diabetes for those of Hispanic/Latino heritage was twice as high (22.6%) than for NHWs (11.3%) and higher than the other racial/ethnic groups included in the study. The age-standardized prevalence of undiagnosed diabetes among Hispanic/Latino adults (49.0%) was significantly higher than that for NHWs (32.3%), and slightly lower than that for non-Hispanic Asians (50.9%) (8).

The baseline examination of the HCHS/SOL (2008–2011) showed that the prevalence of diabetes ranged from 10.2% in South Americans to 18.1% in Dominicans and Puerto Ricans and 18.3% in Mexicans (12). Prevalence by sex ranged from a low of 10.6% for South American men to a high of 18.7% for Mexican men, and from 9.8% in South American women to 19.5% in Puerto Rican women. Diabetes prevalence increased significantly with age and BMI but was inversely associated with years of education and household income (12). Although the prevalence of diabetes also increased significantly with length of residence in the US, it was similar among US-born participants and foreign-born participants residing in the US for fewer than 5 years. However, the prevalence was significantly higher among foreign-born participants with longer than 10 years of residence in the US. Nearly half of Hispanics/Latinos (48%) had adequate glycemic control, a rate slightly lower than those for NHWs (52.9%) and non-Hispanic Blacks (52.6%) who participated in the 1988–2010 NHANES cycles (96). Preliminary data from the second examination of the HCHS/SOL (2014–2017) demonstrated an overall increase in prevalence of diabetes, which is still higher among Mexicans, Dominicans, and Puerto Ricans and lower among Cubans (97).

The HCHS/SOL also determined that nearly 40% of Hispanics/Latinos with diabetes met at least one ADA criterion of undiagnosed diabetes (13). This finding is consistent with a recent NHANES data analysis that showed that Mexican Americans and other Hispanic women were more likely to be unaware of their diabetes status (98).

An additional analysis of HCHS/SOL baseline data found that 36.3% of the target population met at least one of the ADA criteria for prediabetes (97). Prevalence of prediabetes varied by age, sex, Hispanic/Latino heritage groups, and BMI categories, but was similar across place of birth and years living in the US. In the 2011–2012 NHANES cycle, the overall prevalence of prediabetes was 38.0%, and 36.8% for all Hispanics/Latinos (8).

Although there is a paucity of studies examining the prevalence of type 2 DM among children and adolescents, evidence suggests that prediabetes is highly prevalent among Hispanic/Latino adolescents in the US. In a recent analysis based on the 2005–2014 NHANES cycles, the prevalence of prediabetes (based on FPG, 2hPG, or HbA1c) among all Hispanic/Latino adolescents (aged 12–19 years) was 22.9%. Among Mexican Americans it was 22.4%, significantly higher (P = 0.001) than in NHWs (15.1%) (94). Recent data from the Study of Latino Youth, a population-based cross-sectional study of 1,466 Hispanic/Latino youth aged 8–16 years, found a combined prevalence of prediabetes and diabetes (based on FPG and HbA1c) of 16.5% (92), with boys having a higher prevalence compared with girls (20.9 vs. 11.8%, respectively). However, the study did not assess differences by Hispanic/Latino heritage group nor was OGTT available.

The limited number of studies examining the incidence of type 2 DM in Hispanic/Latinos (99–106) indicates that the incidence has been higher than in NHWs across all age groups (99–101) (Table 4). A recent analysis of type 2 DM in children examined in five study centers in the U.S (105) reported an annual rate increase significantly greater for Hispanics/Latinos (3.1%) compared to NHWs (0.6%), but significantly lower than Native Americans (8.9%). However, a recent analysis based on NHANES 2005–2014 cycle did not reveal an increase in incidence in this age group (94).

A few studies have estimated GDM in Hispanics/Latinos (107–114) (Table 5). One of the early studies examining the epidemiology of GDM in an ethnically diverse cohort of over 10,000 women at the Mount Sinai Medical Center in New York City between 1987 and 1990 found a prevalence of 3.2% (107). After controlling for traditional risk factors, first-generation Hispanic/Latino women had a 59% increased risk for GDM compared to NHW women. Kim et al. (112) found that among Hispanic/Latino women, the prevalence of GDM varied by heritage group, from 5.5% among Cubans to 8.7% among Mexicans. Nearly 45% of GDM cases among Hispanic/Latino women were attributable to overweight and obesity, which ranged from 38.5% among Central/South American women to 65.7% among Cuban women. In a recent study of prevalence trends in GDM by race/ethnicity for 19 states, the GDM prevalence increased significantly from 3.71 per 100 deliveries in 2000 to 5.77 per 100 deliveries in 2010 (113). Prevalence of GDM among deliveries increased significantly among all racial/ethnic groups, particularly Hispanics/Latinas, who experienced the highest relative increase (66%).

Diabetes in Latin America

Table 6 illustrates selected studies assessing diabetes in Latin America (115–139). The prevalence of diabetes varies by date in which the studies were performed, methods of assessing prevalence, region and age group (140, 141).

According to a 2015 International Diabetes Federation report, the prevalence of type 2 DM in Latin America was highest in Mexico (14.7%) and lowest in Argentina (6.2%); however, over one-quarter of the Latin American and Caribbean population remained undiagnosed (141). The Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) Study (conducted between 2003 and 2005) (128) reported an age-adjusted prevalence of diabetes of 7.0% in seven urban populations in Latin America (129). The prevalence was highest in Mexico City, Mexico (8.9%) and Bogotá, Colombia (8.1%) and lowest in Lima, Perú (4.4%); it increased with age in all cities, and tended to be higher among women than men. Prevalence of undiagnosed diabetes occurred in 20% of adults with diabetes. The Latin American Consortium of Studies in Obesity (LASO) (which included 11 studies conducted in eight countries between 1999 and 2008) (132) reported an average prevalence of 5%, which increased from 0.9% in participants aged 20–29 years to 16.4% in those aged 70 or older (133). However, the prevalence of diabetes in Latin America and the Caribbean was similar to the US population (NHANES, 1999–2004), after accounting for differences in the age distribution. Puerto Rico had the highest prevalence among the countries included in the analysis.

More recent Latin American studies include the Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil) (134), which reported a prevalence of 19.7% (based on self-report or FPG, 2hPG and HbA1c), of which about half was undiagnosed (135); the Centro de Excelencia en Salud Cardiovascular para el Cono Sur I (CESCAS I), which reported an overall prevalence (based on FPG only) of 12.4% across four sites in Argentina, Chile, and Uruguay (136); and the Centro de Excelencia de Enfermedades Crónicas (CRONICAS), which reported an overall prevalence of 7.1% (based on FPG only) across four regions in Perú (139).

One of the few studies in Latin America and the Caribbean that estimated the incidence of type 2 DM is the Mexico City Diabetes Study, which focused on the population aged 35–64 years over 18 years of follow-up (143) (Table 7). Cumulative incidence rates of type 2 DM for men and women were 14.4/1,000 and 13.7/1,000, respectively. Incidence was 15.8, 15.7, and 12.7 per 1,000 person-years for the follow-up studies conducted in 1994, 1998, and 2008, respectively. These figures suggest that this population has one of the highest diabetes incidence rates worldwide, and that incidence rates have remained fairly stable.

Other CV Risk Factors in Hispanics/Latinos

Overweight/Obesity

In the most recent NHANES examination (2013–2014 cycle), the age-adjusted prevalence of obesity in adults (>20 years) was 37.1% for NHWs and 42.7% for Hispanics/Latinos, with Hispanic/Latino men and women having 21% and 33% increased odds of obesity compared to NHWs, respectively (144). In the most current NHANES examination, the prevalence of obesity in children was 14.7% for NHWs and 21.9% in Hispanics/Latinos, and extreme obesity was 4.4% in NHWs and 7.6% in Hispanics/Latinos (145). In the baseline examination (2008–2011) of the HCHS/SOL, 77% of participants had overweight or obesity, and the age-adjusted prevalence of obesity ranged from 26.8% in South American men to 51.4% in Puerto Rican women (84). However, enlarged waist circumference (≥102 cm in men and ≥88 cm in women) was highly prevalent among men (73%) and women (96%), independent of the heritage group (146). A higher prevalence of overall obesity in women compared to men, and high prevalence of abdominal obesity have also been described in Puerto Rico (147, 148).

The CARMELA study reported an overall obesity prevalence of 23%, ranging from 16% in Quito, Ecuador to 31% in Mexico City, Mexico (128). The LASO reported that overall obesity ranged from 13.8% in men to 18.4% in women, and that abdominal obesity ranged from 15.4% in men to 55.5% in women (133). CESCAS I reported a prevalence of 35.7% obesity and 52.9% central obesity (136), whereas CRONICAS reported a prevalence of 44.0% overweight and 26.0% obesity among individuals without diabetes, and 40.8% overweight and 39.9% obesity among those with diabetes; and enlarged waist circumference in 71.5% without diabetes and 88.5% with diabetes (139); and in ELSA-Brasil, 40.2 and 22.9% had overweight and obesity, respectively (149). Although the prevalence of obesity in some regions of Latin America has been lower than that of Hispanics/Latinos in the US, in others it is comparable.

A systematic review of studies published between 2008 and 2013 estimated that the prevalence of overweight and obesity for children and adolescents throughout Latin America ranged from 18.9 to 36.9% in children aged 5–11 and 16.6 to 35.8% in adolescents aged 12–19 (150). An obesity trend analysis from Mexico (2012) revealed a significant increase during the same time frame in which obesity increased in the US (145, 151). The prevalence of overweight/obesity also increased in Colombia from 38.2% in 2000 to 43.1% in 2010 (152).

Hypertension

In the 2009–2010 NHANES cycle, the age-adjusted prevalence of hypertension among US adults was 29.8% for NHW men, 26.9% for NHW women, 26.3% for Mexican American men, and 27.7% for Mexican American women (153). In the HCHS/SOL, the age-adjusted prevalence of hypertension was 25.5% (154).

In CARMELA, hypertension prevalence ranged from 7.2% (men) and 10.1% (women) in Ecuador to 37.7% (men) and 21.7% (women) in Argentina (155). LASO reported a mean prevalence of 20.2% (133). CRONICAS reported a prevalence of 23.9% for individuals without diabetes, and 50.9% for individuals with diabetes (139). ELSA-Brasil reported a mean prevalence of 25.7% in women and 34.5% in men (149). In CESCAS I hypertension prevalence ranged from 36.9% in Temuco, Chile to 45.3% in Bariloche, Argentina, and a mean of 40.8% in Chile, Argentina, and Uruguay (136).

Dyslipidemia

In the 2011–2012 NHANES cycle, prevalence of high total cholesterol was 13.5% in NHWs and 14.2% in Hispanics/Latinos, and the prevalence of low high-density lipoprotein cholesterol (HDL-C) was 17.1% in NHWs and 21.8% in Hispanics/Latinos (156). In the HCHS/SOL, the prevalence of elevated total cholesterol was 13.9% in women and 14.3% in men, elevated low-density lipoprotein cholesterol (LDL-C) was 34% in women and 38.2% in men, triglycerides (TGs) > 200 mg/dL was 10.2% in women and 19.8% in men, and low HDL-C was 47.9% in women and 34.3% in men (157).

In CARMELA, the prevalence of hypercholesterolemia ranged from 5.7% in Barquisimeto, Venezuela to 20.2% in Quito, Ecuador (128). CESCAS I reported an overall prevalence of hypercholesterolemia of 24.4% (which ranged from 20.8% in Bariloche, Argentina to 31.0% in Barros Blancos, Uruguay), high LDL-C of 23.1%, low HDL-C of 34.1%, and hypertriglyceridemia of 22.1% (136). LASO reported an overall prevalence of 8.9% of elevated total cholesterol, 8.5% of high LDL-C, 53.3% of low HDL-C, and 26.5% of high TGs (133). ELSA-Brasil reported a mean prevalence of hypercholesterolemia of 68.2% in women and 65.5% in men (149). Although the prevalence of lipid and lipoprotein abnormalities varies by region and study, it seems like low HDL-C is highly prevalent across Hispanic/Latino populations in the US and Latin America.

Tobacco Use

The prevalence of smoking among US adults is 16.7% for men and 13.6% for women, with distinct racial/ethnic differences (158). The prevalence among NHWs is 20.2%, and 10.1% for Hispanics/Latinos, nationwide. However, the HCHS/SOL demonstrated a higher overall prevalence of daily smoking (16.9% in men and 10.7% in women) and significant differences among heritage groups with higher prevalence of daily smokers in Puerto Rican men (27.0%), Cuban men (26.2%) and Puerto Rican women (24.2%), and lower smoking prevalence in Dominican men (8.8%) and Mexican women (4.4%) (159).

In Latin America, the CARMELA reported a prevalence of current smoking that ranged from 21.8% in Barquisimeto, Venezuela to 45.4% Santiago, Chile (128). LASO reported a mean prevalence of 25.8% (133), and CESCAS I reported a mean prevalence of 29.7% in Argentina, Chile, and Uruguay (136). ELSA-Brasil reported a mean prevalence of current smoking of 15.5% in women and 16.7% in men (149). In contrast, CRONICAS reported a prevalence of daily smoking of 3.3% among individuals without diabetes, and 2.7% among those with diabetes in Perú (139).

Behavioral Risk Factors

Cardiometabolic factors are influenced by modifiable behavioral risk factors, namely physical activity (PA), and dietary intake. The 2010 Racial and Ethnic Approaches to Community Health Risk Factor Survey estimated approximately one-third of Hispanic/Latino men and women met PA recommendations (160). Moreover, using objective measures, the HCHS/SOL reported that Hispanic/Latino adults spent 11.9 h/day, or 74% of their monitored time, in sedentary behaviors, with less time for Mexicans and more for Dominicans (161). CESCAS I reported a prevalence of physical inactivity of 35.2% (136); ELSA-Brasil reported a mean prevalence of physical inactivity of 79.8% in women and 70.9% in men (149).

In the HCHS/SOL, differences in total energy, macronutrient, and nutrient-dense intakes were observed among the different heritage groups (162), with higher total energy and macronutrient intakes by Cubans, higher fiber intake by Mexicans, lower fiber intake by Puerto Ricans and lowest total energy intake by Dominicans. Evaluations of the dietary intake and quality based on the 2010 Alternate Health Eating Index and the Dietary Approaches to Stop Hypertension (DASH) revealed overall low scores for intakes of whole grains, and fruit and vegetables with lower dietary quality for Puerto Ricans and higher quality for Mexicans (163, 164).

Dietary patterns in Latin America have been gradually shifting toward increased consumption of sugars and meat, and decreased consumption of fruit and cereals across the continent (165, 166). In CESCAS I, 85.5% of participants reported low intake of fruits and vegetables (136). CRONICAS reported that 3.8% of individuals without diabetes and 9.5% with diabetes consumed 5 or more servings of fruits/vegetables per day (139). ELSA-Brasil reported low health dietary scores (1.23–1.38 out of 5) (149).

Etiology of Type 2 DM in Hispanics/Latinos

Multiple factors contribute to type 2 DM risk including: genetic variations, demographic characteristics, and behavior- and lifestyle-related risk factors (167). Among the pathophysiologic defects in type 2 DM, insulin resistance along with β-cell failure are considered major defects (168). Alterations in the adipose tissue (endocrine organ), the gut incretin-system (enteroinsular axis), renal reabsorption of glucose, and brain insulin response also play important roles in the development of glucose intolerance and type 2 DM (169). In addition, alterations in the crosstalk between immune and metabolic pathways are closely linked to obesity and diabetes (170). Inflammation is also recognized as a common pathway for the major complications of atherosclerosis, stroke, and ischemic heart disease, commonly observed in persons with diabetes (171). Some of these aspects have been studied in Hispanics/Latinos.

Obesity and Insulin Resistance

As reported in other ethnic groups, type 2 DM is associated with obesity in Hispanics/Latinos (172). However, obesity does not explain the excess diabetes prevalence among Hispanics/Latinos compared to NHWs (172). For instance, 29.3% of participants of HCHS/SOL with prediabetes had normal weight (95). On the other hand, duration of obesity or earlier age of onset has been associated with increased risk of developing type 2 DM (173–175).

In addition to overweight or obesity, the distribution of the adipose tissue has been associated with increased risk for type 2 DM and CVD. Non-alcoholic hepatic steatosis, for example, has been described in some Hispanic/Latino groups, and has been linked to increased insulin resistance and other cardiometabolic abnormalities (176, 177).

Data from the SAHS showed that insulin resistance measured by several insulin resistance surrogates accounts for a significant proportion of the excess type 2 DM risk in Mexican-Americans compared to NHWs (178). This study also showed evidence of higher all-cause and CV mortality among Hispanics/Latinos born in the US (179).

Adipokines, Hypercoagulability, Inflammation, and Endothelial Dysfunction Biomarkers

Several adipokines and inflammation and hypercoagulability mediators, such as leptin, intercellular adhesion molecule-1, tissue plasminogen activator, inhibitor of plasminogen activator-1, high-sensitivity C-reactive protein (CRP), macrophage chemoattractant protein 1 (MCP-1), tumor necrosis factor (TNF)-α, and interleukin-6 (IL-6) have been found to be elevated in young Hispanics/Latinos at high risk of developing type 2 DM (180–189) and individuals from different racial/ethnic groups—including Hispanics/Latinos—with type 2 DM (189–194). Elevated IL-6, leptin, CRP, and TNF-α have been observed in Mexican Americans with type 2 DM, and the elevation IL-6 and leptin in particular was linearly associated with increasing glycemia (194).

For example, in a prospective study of Hispanic/Latino adolescents with obesity, higher baseline MCP-1 or IL-6 levels at prepubertal age were associated with a 16 and 21% greater decline in insulin sensitivity during puberty (195). However, this relationship between proinflammatory/endothelial dysfunction markers and insulin sensitivity has been shown to vary with adipose tissue distribution, and may differ across racial/ethnic groups (188, 192). Adiponectin, a collagen-like protein secreted from adipose tissue has been inversely correlated with both insulin sensitivity and adiposity (196–198), and increased risk of developing type 2 DM in Hispanic/Latino adults (199). Adiponectin inversely correlates with CV risk factors in older adults (200), and appears to predict progression to glycemic failure in adolescents with type 2 DM from different ethnic groups (200, 201). A cautionary note: Most of these studies have been small, and the representation of Hispanic/Latino heritage groups has been very limited.

Other Factors

Maternal factors such as fasting indexes of total triiodothyronine, insulin, leptin, and ghrelin have been associated with excessive weight gain in Hispanic/Latino children (202–204). Women who experience GDM are at high risk of developing GDM in subsequent pregnancies (205, 206) and type 2 DM (205). In addition, children born to women with GDM are at increased risk of obesity and glycometabolic disease later in life (204–214). Increased proinflammatory markers have also been identified in women with GDM (215). Research studies involving Hispanic/Latino women in the US or in Latin America have described increased proinflammatory markers (e.g., proinflammatory cytokines and/or natural killer cells) at the placental level (216–218), and at both the placental and fetal level (219) associated with maternal hyperglycemia during pregnancy. In Mexican women, prepregnancy overweight and obesity have been associated with increased oxidative stress in the newborn (220). In Chile, in women with overweight or obesity and GDM, maternal elevated TGs were associated with increased infant’s birth weight (BW), despite good maternal glucose control (221). Maternal hyperglycemia, whether due to preexisting diabetes or GDM, has been associated with increased oxidative stress and maternal DNA damage (222, 223), and both placental and umbilical cord DNA damage (222, 223). However, the number of patients in these studies has been small, and the interaction of obesity or other proinflammatory factors cannot be separated from hyperglycemia. Whether these changes could be prevented or reversed is unknown.

Low BW, like maternal GDM, has been inversely associated with glucose intolerance and insulin sensitivity during childhood and increased risk for CVD later in life. This susceptibility to adult chronic diseases may be a response to exposures in utero—known as fetal programming—or early malnutrition in extra uterine life (224, 225). Several studies in Latin America have documented the inverse association between BW and insulin sensitivity later in life (226), malnutrition during the first year of life and insulin sensitivity, glucose tolerance and metabolic syndrome later in life (227–229); and being exclusively or predominantly breastfed > 12 months and lower adiposity and serum cholesterol during childhood (230).

Chronic malnutrition is associated with alterations in glucose metabolism and insulin sensitivity (231). Decades ago, a malnutrition-modulated diabetes or tropical diabetes was described in developing countries (232, 233). Some investigators hypothesized that consumption of cassava (manioc or tapioca) could lead to diabetes in malnourished subjects, due to cyanogenic glycosides leading to chronic pancreatitis; however, the theories remained largely speculative (232). Others postulated that chronic protein energy malnutrition would cause persistent insulin deficiency and glucose intolerance without ketosis, among other clinical features (234–236).

A link between plasma branched-chain amino acids (BCAAs) and insulin clearance has been observed in recent years. Overweight persons exposed to a diet high in saturated fat have been found to have a significant inverse correlation between plasma BCAAs and insulin clearance. This association has also been observed in Hispanics/Latinos (237).

Atypical forms of diabetes such as ketosis prone diabetes (KPD) have also been described in Hispanics/Latinos. KPD affects 20–50% of African-American and Hispanic/Latino patients with new diagnoses of diabetic ketoacidosis (238). Hispanics/Latinos with KPD also appear to be disproportionally affected by KPD characterized by an absence of autoantibodies and presence of β-cell functional reserve (239, 240).

Sleep disruptions characteristic of obstructive sleep apnea (OSA) and that alter sleep duration and timing may promote behavioral, metabolic, and/or hormonal changes associated with changes in weight (241–244). OSA is independently associated with insulin resistance (245) and predicts subsequent risk for type 2 DM (246). In the HCHS/SOL, both quantity and quality of sleep were associated with higher odds of having type 2 DM (247, 248) and impaired glucose tolerance (IGT) (247) with the greatest odds among those with short sleep duration and insomnia (249). Three loci have been found to be significantly associated with OSA traits in a large genome-wide association study of 12,558 Hispanics/Latinos (250). The association of fasting blood glucose and OSA was weaker among Hispanics/Latinos in MESA compared to African Americans (AA) and NHWs (251).

In recent years, Alzheimer’s disease (AD) has been considered as a metabolic disease mediated by alterations in brain insulin responsiveness, glucose utilization, and energy metabolism that can lead to increased oxidative stress, inflammation, and worsening insulin resistance (252). The association between type 2 DM and AD has been called type 3 diabetes (253). Mexican American elders with diabetes are at almost twofold increased risk of dementia than those without diabetes (254). Also, longer duration of diabetes has been associated with a faster rate of cognitive decline in this age group (255). Further research is needed to examine the interaction of type 2 DM and AD in this vulnerable group, and among other Hispanic/Latino groups.

Other emerging risk factors for type 2 DM and CVD include the gut microbiome (256–258), gallbladder disease (259), environmental exposures (260–262), and the impact of sugar-sweetened beverages intake on satiety (263). Research on these emerging factors in Hispanics/Latinos has been limited.

Genetics and Type 2 DM in Hispanics/Latinos

The polygenic nature of type 2 DM is well established and more than 100 loci for type 2 DM and glycemic traits have been identified through genome-wide association studies (GWAS) of common and rare variation in populations of diverse ancestral origins (264).

Genetic variations in the gene encoding for transcription factor 7-like 2 (TCF7L2) have been associated with type 2 DM in different populations (265). The T allele of single nucleotide polymorphism (SNP) rs7903146 of TCF7L2 strongly predicts the development of type 2 DM (265, 266). TCF7L2 has been associated with GDM and type 2 DM in Hispanics/Latinos of Mexican descent (267, 268), and polymorphisms of this gene have been associated with reduced acute insulin response in this heritage group (269). This gene has also been associated with diabetes in the HCHS/SOL (270). TCF7L2 polymorphism rs7903146 has also been associated with coronary artery disease (271, 272) and stroke (273) among patients with long standing history of type 2 DM.

A haplotype containing four missense SNPs, all in SLC16A11, conferring 20% increased risk for type 2 DM was identified through GWAS in Mexican and other Latin American samples in the SIGMA type 2 DM Consortium (274). A newly identified African ancestry-specific allele at KCNQ1 was associated diabetes in HCHS/SOL (270), however, the mechanisms leading to type 2 DM due to alterations in this allele are less well understood (275).

Whole-exome sequencing in 3756 individuals of Mexican and Mexican American ancestry identified a rare variant (p.E508K) in HNF1A that had significant association (fivefold increase) with type 2 DM (276). HNF1A is the gene responsible for MODY3, a monogenic, early-onset form of type 2 DM, however carriers of p.E508K did not show early-onset of type 2 DM and were indistinguishable from the wider type 2 DM population, thus not fulfilling the classical diagnostic criteria for MODY3 (276).

The Genetics Underlying Diabetes in Hispanics/Latinos (GUARDIAN) Consortium (277) conducted a GWAS in multiple Mexican-ancestry cohorts with highly detailed glucose homeostasis measures. Nonparametric meta-analysis of the Discovery and Translation cohorts identified a significant relationship with type 2 DM phenotype at 6p24 (SLC35B3/TFAP2A) in association with glucose effectiveness, 11p15 (KCNQ1) with disposition index, and 6p22 (CDKAL1) and 11q14 (MTNR1B) with acute insulin response (277).

Genetic studies of GDM in Latin American women have yielded varied findings. In Brazilian women, GDM has been associated with the glucokinase gene (278), the MTNR1B gene polymorphism rs10830963 (279), LGALSI polymorphism (280) and IRS-1 (281). In Mexican women, GDM has been associated with polymorphisms of the HNF4A gene (282), the TNF-α gene promoter (283), the MTNR1B gene (284), the CENTD2 gene (284), the KCNQ1 haplotype (284), and the TCF7L2 gene (284, 285). However, polymorphisms of the fat mass and obesity-associated (FTO) and the TCF7L2 genes have not been associated with GDM in Brazilian women (286), and SLC16A11 locus was not associated with GDM in Mexican women (284).

Among Mexican American subjects recruited in the San Antonio Family Heart Study, DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1, and SAMD12) independently explained 7.8% of the heritability of type 2 DM (287). In the same population, individuals with the hypertriglyceridemic waist phenotype [waist circumference ≥95 cm in men and ≥80 cm in women] combined with high serum TG concentration (≥2.0 mmol/L in men and ≥1.5 mmol/L in women) were found to have epigenetic changes (DNA methylation) in genes involved in β oxidation of long-chain fatty acids (CPT1A) and triglyceride storage (ABCG1) (288).

In summary, these findings have shown the broad complexity of the pathophysiology of metabolic disease and research focused on Hispanics/Latinos. Broader attention to different heritages should be considered in future studies to better stratify subjects at risk for type 2 DM and develop intervention strategies according to different genotypic and phenotypic traits.

Interventions to Prevent Type 2 DM among Hispanics/Latinos

Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Women with History of GDM

The increasing prevalence of obesity and metabolic disease in young Hispanics/Latinos (and other racial/ethnic groups) has raised thought-provoking questions about the role of maternal health and the intrauterine environment on the child’s future risk for type 2 DM and obesity. As previously described, women who experience GDM are at high risk of developing GDM in subsequent pregnancies and type 2 DM, and their children are at increased risk of metabolic disease.

The quality of dietary fat intake (289) and PA (290–293) during mid-pregnancy have been as proposed factors that could influence the risk of GDM in Latin American women. However, clinical studies evaluating the effect of exercise training on pregnancy outcomes have yielded inconsistent or even conflictive results (292, 294). In a systematic review by Perales et al., the authors concluded that the combination of aerobic and resistance training during pregnancy seemed to produce the most favorable effect on different maternal health parameters, but that this combination (or either type of exercise separately) yielded an overall weak effect on reducing GDM (294). Previous history of GDM, preexisting overweight or obesity, gestational weight gain, intensity, frequency, duration, and timing of exercise, and adherence to the PA regime may be factors impacting program efficacy (292, 294).

Research focused on preventing GDM or type 2 DM in women with a history of GDM—especially Hispanics/Latinas—has been scarce. Some studies have evaluated PA and weight gain/retention during pregnancy or postpartum (295–297). In the Behaviors Affecting Baby and You Study (n = 110 women at risk of GDM, 60% Hispanic/Latina) participants were randomized to either a 12-week tailored PA intervention or usual wellness care (295). Women on the tailored exercise intervention had smaller decrease in postpartum PA than the control group (−1.0 MET-hours/week versus −10.0 MET-hours/week). In the Diet Exercise and Breastfeeding Intervention Study (n = 116, 35.5% Hispanic/Latina), pregnant women with GDM were randomized to either a Diabetes Prevention Program (DPP)-modeled intervention that started during pregnancy and continued postpartum, or usual care to determine feasibility and changes in metabolic parameters (296). In a subsample of 72 participants, women who had lost > 2 kg experienced lower increases in fasting glucose, 2h-glucose and homeostasis model assessment of insulin resistance (HOMA-IR) at 12 months postpartum. Hispanic/Latino women were more likely to maintain or gain weight postpartum than women from other racial/ethnic groups (296).

In the Gestational Diabetes’ Effects on Moms Study (n = 2,280 women with GDM, 22.2% Hispanic/Latina), a DPP-modeled intervention between 6 weeks and 6 months postpartum was compared to a usual care (mailed recommendations only) (297). The intervention arm had 28% higher odds of meeting postpartum weight goals than usual care. A greater proportion of women on the intervention arm had less weight retention at 6 weeks (25.5 vs. 22.4%) and 6 months postpartum (30.6 vs. 23.9%, mean weight lost = 1.89 vs. 0.94 kg) compared to the women in usual care. However, the difference was no longer significant at 12 months (33.0 vs. 28.0%, mean weight lost = 1.19 vs. 0.50 kg). Also, at 6 months postpartum, the intervention arm had a greater increase in vigorous-intensity PA (mean 15.4 min/week) than usual care.

In the Parish Nurse Intervention Program (298), 100 Mexican American women with GDM were randomized to an interview-based intervention assessing health-promoting behaviors and lifestyle or to usual care. At postpartum, intervention participants reported higher scores on health-promoting behaviors than women receiving usual care. While promising, there were no significant differences in blood glucose, HbA1c, macrosomia, and other biometric parameters. In the Dulce Mothers Project, 84 Hispanic/Latino women with previous GDM were randomized to a shortened 8-week DPP-modeled intervention, or usual care (299). After 6 months, intervention participants reported a significantly higher PA and lower fat intake, but there were no changes in body weight or BMI. Although changes in HbA1c% (5.73–5.82%), total cholesterol (180–169.9 mg/dL), LDL-C (107.8–100.4 mg/dL), and TGs (124–110.3 mg/dL) were statistically significant, they were not clinically significant. In the Estudio Vida (300), 68 pregnant Hispanic/Latino women of unspecified ancestry were randomized to a 6-month culturally and linguistically modified lifestyle intervention (monthly in-person behavioral counseling, and five telephone-delivered booster sessions, plus follow-up 6 weeks postpartum) or to usual care, to compare PA, gestational weight gain, infant BW, and biomarkers of insulin resistance postpartum. Although the intervention was shown to be feasible, no changes were observed in any of the outcomes (300).

Some of the studies described above did not report the Hispanic/Latino heritage group of the participants and/or assess cardiometabolic markers. In addition, it is unknown whether the follow-up of participants continued beyond the intervention period, and whether the risk for future GDM or type 2 DM was reduced. Other interventions focused on Hispanic/Latino women with history of or at risk of GDM and involving lifestyle intervention have been proposed (301, 302) have been proposed or initiated. However, results have not yet been published.

Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Youth in the US and Latin America

Little information is available of type 2 DM prevention efforts focusing on the youth (303). To date, no published investigations are available to address type 2 DM prevention in Hispanic/Latino youth with prediabetes. Although programs designed to prevent childhood and youth obesity have been extensively reviewed, these seldom assess blood pressure, lipids and lipoproteins and other metabolic markers, or adiposity (304–311). The effectiveness trials for prevention of type 2 DM among youth are further challenged by a lack of consensus on parameters for disease risk indicators (adiposity, CV risk markers, resting energy expenditure), especially during puberty, and its associated changes in body composition, insulin sensitivity and or insulin secretion (312–317).

Weight Loss and Obesity Prevention Trials

Weight loss interventions focusing on children with overweight or obese have resulted in improved metabolic outcomes such as insulin sensitivity, lipids and adiposity measures (318–324). Most of these trials involved medium to high-intensity interventions focusing on physical activity (PA) and dietary intake (309, 311, 325). Interventions delivered in schools with home involvement (PA-only interventions), or with home and community components (diet and PA interventions) have produced the strongest evidence of the metabolic benefits of weight loss and, consequently, childhood obesity prevention in the US and Latin America (310, 325, 326).

While promising, there are few weight gain prevention interventions specifically focusing on Hispanics/Latinos in the US and Latin America (304, 308, 327). Reviews of childhood obesity interventions in Latin America and the Caribbean report encouraging trends in childhood obesity prevention and treatment programs in schools (328), healthcare (329), and settings such as home, summer camps and family clinics (330). However, these studies were mostly carried out in Mexico and Brazil, only three were randomized clinical trials (RCTs), and most did not include appropriate pediatric measures for BMI or participants’ ages (327). In the US, evaluations of community-based interventions targeting multiple predictors of childhood obesity are underway via the CDC-funded Childhood Obesity Research Demonstration Projects (CORD) (331–334). Two of the sites will focus specifically on Hispanic/Latino populations.

Dietary Considerations

Although there is no prescribed diet for diabetes prevention among youth, reductions of saturated fats and sugars and increases in fruits, vegetables, and fiber are expected to prevent overweight among children (335, 336) and therefore are also used in weight loss intervention trials. However, some argue that diets for type 2 DM prevention among youth should instead focus on low-glycemic foods (337). Small trials that test the safety and efficacy of intense diet modifications suggest that low-glycemic food choices decrease waist circumference, BMI z-score, and insulin resistance—assessed through the HOMA-IR—compared to higher glycemic food choices (323, 325, 337–341). Some authors argue that these diets lead to greater decreases in adipose tissue compared to low-energy and low-fat diets (338, 342). In terms of metabolic effects of these diets specifically among Hispanics/Latinos, evidence is still emerging (325).

Physical Activity Considerations

Intervention trials involving exercise only (without diet restrictions) among youth and adults have shown effects on metabolic outcomes and cardiorespiratory fitness without affecting weight or fat mass (343–349). Data specific to Hispanics/Latinos are limited, but in Mexico, Macías-Cervantes et al. observed a significant decrease in insulin and HOMA-IR after a randomized trial of a 12-week exercise training intervention in a RCT of 76 children, aged 6–9 years, with no significant changes in BMI or diet between control and intervention groups (347). Of note, the ADA recommends that children engage in 60 minutes of exercise per day most days, and that they limit time in front of a screen to less than 2 hours a day as a type 2 DM prevention strategy in children (336).

Preventing Prediabetes in School-Aged Children

DPPs in school settings have been somewhat successful at increasing PA (and sometimes improving diet) via education and hands-on activities. However, their effects on BMI, adiposity measures, and lipids have been inconsistent (305, 350–353). Results are difficult to compare due to the range of both the cardiometabolic risk indicators assessed and the age of the children included in the studies.

Lifestyle intervention trials have been conducted in schools with large (>50%) Hispanic/Latino populations to achieve change in metabolic and anthropometric outcomes among normal-weight students. These interventions have often involved PA and healthful nutrition education components and activities that are incorporated into the schools’ curricula (regular and PA classes) and cafeteria. After 4–7 month interventions involving elementary- and middle-school children, several studies reported significant improvements in behavioral or metabolic outcomes, without an effect on anthropometrics (354–356). Two additional studies with similar school-based programs reported improvements in metabolic and anthropometric parameters in the US and Brazil (350, 357), yet, not all studies have yielded significant results. For example, the HEALTHY study, a larger school RCT in seven centers in the US in which children in middle school (sixth to eighth grade, 54.2% Hispanics/Latinos) were followed, did not observe significant decreases in overweight/obesity, lipid, hypertension, or other metabolic markers among Hispanics/Latinos (358, 359).

Studies that focus on older Hispanic/Latino youth (aged 14–17 years) are less consistent in their findings. A small RCT in Brazil (360) reported that a high-intensity exercise intervention for 43 adolescents with obesity did not improve BMI, waist circumference, blood glucose, physical fitness, HDL-C, or lipids. Other studies in older Hispanic/Latino teenagers (14–17 years) with obesity in the US or Mexico used similar dietary intake-targeted interventions for an average 4-month period. Although they reported significant changes in some anthropometric measures, physical inactivity, diet, and cardiometabolic risk factors, they were insufficiently powered and did not include controls (361–363).

Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Adults in the US and Latin America

The evidence for successful type 2 DM prevention interventions among adults is growing. However, the increasing prevalence and incidence of type 2 DM among Hispanic/Latino adults suggest that preventive programs have not caught up with the needs of this population.

The DPP

The DPP is a seminal type 2 DM prevention trial (364). It recruited an ethnically diverse (N = 3,234, 16% Hispanics/Latinos) cohort and established a multisite program that demonstrated that a lifestyle intervention targeting 7% body weight reduction and increase in PA (goal = 150 minutes per week) effectively reduced by 58% (compared to placebo) the incidence of type 2 DM among persons at high risk, and compared to 31% reduction with metformin (364, 365). The reduction of diabetes incidence was similar among race/ethnic groups, including Hispanics/Latinos (364). The percent of weight loss achieved by Hispanics/Latinos in the lifestyle intervention arm (women 7.3%, men 7.7%) was close to that of NHWs (women 7.9%, men 8.5%) (366).

Lifestyle Interventions Modeled after the DPP in Hispanics/Latinos in the US

The success of the DPP has sparked numerous attempts to modify this individual-based intervention for delivery in various community settings serving culturally diverse groups (367–379). Many of these translations appear to be effective for weight loss and improvement in cardiometabolic parameters (368, 379), although questions remain as to appropriate dosage that makes interventions both accessible and cost-effective, as well as the way in which these interventions have been culturally adapted to different populations.

A recent review identified only five RCTs designed to evaluate lifestyle interventions aimed to reduce risk of type 2 DM in Hispanics/Latinos (measured by reduction of weight or HbA1c) (380), and only two were deemed to have a strong quality rating. These two studies were conducted in women only (370) or mostly (>70%) (368), and only one of them reported a significant reduction in HbA1c (368).

Most studies designed for type 2 DM prevention among Hispanics/Latinos culturally tailor their programs to the population of interest (367–369, 371, 381). A recent review of culturally tailored type 2 DM prevention interventions in US Hispanic/Latino adults described the varied approaches to cultural tailoring, which ranged from use of bilingual materials to community input on program content (380). As is the case in virtually all culturally adapted studies, none assessed the relative importance of various cultural adaptation elements, did not compare culturally adapted interventions and non-adapted approaches (380), and did not specify participants’ ancestry or country of origin. While budgetary limitations often present barriers to these analyses, it would be important to ascertain the usefulness of elements of cultural adaptation, as well as to determine the variability of health-related behaviors by cultural origin (84, 163, 382–384). There is a critical need for culturally adapted interventions to provide more detailed information on the methodology followed in the cultural adaptations, beyond the translation of materials, as well as to address the linguistic needs of many Latin American immigrants from indigenous communities, for whom Spanish is not a first language.

In Latin America, there seem to be no published studies modeled after the DPP, but several RCTs have evaluated the effect of lifestyle interventions on weight and metabolic outcomes among adults in Mexico and Brazil (384). The RCTs varied in size (N = 51–241), intervention dosage (weekly to monthly), duration (6–12 months), and specific intervention components. The dietary interventions included the DASH diet (385), low-glycemic diets (386), or diets recommending olive oil, fruits, and vegetables (387). The studies reported significant changes in body weight loss and/or metabolic markers, including fasting blood glucose, HbA1c, and lipids (386–390).

Pharmacological Interventions to Prevent Type 2 DM in Hispanic/Latino Adults in the US and Latin America

A few pharmacological interventions focused on preventing or delaying type 2 DM in Hispanics/Latinos have been published (391–395). The PPAR γ agonists troglitazone (391) and pioglitazone (392) have demonstrated long-term preservation of β-cell function in Hispanic/Latino women with a history of GDM. Troglitazone significantly reduced the annual incidence rate of type 2 DM (5.4 versus 12.1% for placebo) over a median 30-month follow-up (391), and pioglitazone demonstrated a significant decrease over 1-year period (392).

Boyko et al. reported a significant and greater reduction in diabetes incidence (hazard ratio = 0.18 over approximately 5 years, P = 0.0242) in Latinos taking rosiglitazone, another PPAR γ agonist, and South Asians showing the lowest reduction (393). De Fronzo et al. reported a similar effect of pioglitazone at reducing diabetes incidence (hazard ratio = 0.28 over 2.4 years, P < 0.0001) among NHWs, AAs and Hispanics/Latinos compared to placebo (394).

O’Brien et al. (395) compared a 12-month intensive lifestyle intervention (DPP-modeled) led by promotoras to metformin, and to usual care in a group of 85 Hispanic/Latino women (aged ≥ 20 years) with prediabetes (IFG and/or HbA1c 5.7–6.4%). The investigators observed a significant reduction in weight (−4.0 kg or 5.0%, P < 0.001) as well as in BMI in women on the lifestyle intervention compared to the other groups. However, no significant changes in blood pressure, biochemical parameters, or HOMA-IR were observed. Of note, the mean adherence to metformin was 66.4%.

Pharmacological Interventions for Cardiometabolic Risk Factors in Hispanic/Latino Adults in the US and Latin America

Pharmacological interventions specifically designed to improve cardiometabolic risk factors in Hispanics/Latinos at high risk of type 2 DM are limited. Despite this limitation, we would like to highlight some key findings.

Four RCTs (396–400) designed to compare the effectiveness of combinations of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) on blood pressure reduction and/or prevention of CV events with other antihypertensive medications reported that Hispanics/Latinos demonstrated good response to the therapies and maintenance of blood pressure control, similar or even superior than that observed in NHWs (396–399). In one of the trials, the addition of trandolapril to the treatment was associated with a lower incidence of diabetes and CV events among Hispanics/Latinos than in non-Hispanic participants (398). This observation is consistent with previous clinical trials (in which Hispanics/Latinos had not been included) that reported a lower incidence of type 2 DM associated with ACE inhibitors and ARBs (401, 402). Also, a secondary data analysis on one of the trials revealed that a significantly larger percent (75%) of Hispanic/Latino women (n = 5,017) reached blood pressure goals compared to 68% of NHW women (n = 4,710), and that Hispanic/Latino women experienced fewer CV events (5.7 versus 12.3%) (403). In addition, Punzi et al. reported a significant reduction in blood pressure in Hispanics/Latinos with Stage I-II hypertension associated with nebivolol (β blocker) (404). Blood pressure control was achieved by 32–71% of participants depending on the dose. Some of these studies reported the Hispanic/Latino heritage group of the participants or the Latin American countries where the studies were conducted. Other studies did not report nationalities or heritage group.

The results of the studies described above suggest Hispanics/Latinos experienced similar or better response to antihypertensive therapy than patients from other demographic groups (405). In contrast, Yi et al. did not observe an increased blood pressure control with self-blood pressure monitoring in a low-income urban setting (406). Thus, the good response to hypertensive medications observed among Hispanics/Latinos in clinical trials may be both physiological and dependent on a controlled research setting. Future research may address underlying self-efficacy and contextual barriers that impeded the success of the self-monitoring and blood pressure control outside of clinical trials.

Various clinical trials evaluating the efficacy of lipid-lowering agents have reported significant reductions of total cholesterol and LDL-C, or CRP in US Hispanics/Latinos or Latin Americans (407–410), and comparable to reductions experienced by NHWs (407, 408). These studies have also reported good medication tolerance.

Policies and Priorities and Diabetes Prevention Research in Latin America

Countries throughout Latin America and the Caribbean are starting to raise awareness about chronic disease, including type 2 DM treatment and prevention. For example, the Latin American Association for Diabetes published guidelines about the treatment and management of type 2 DM across medical associations in 17 countries (411). During the 2016 Pan American Health Organization (PAHO) symposium on Diabetes in the Americas, various countries described the epidemiology of diabetes in terms of incidence, prevalence, mortality, and risk factors. The review discussed policies or public awareness programs in place or designed to raise awareness of diabetes management focused mostly on nutrition education and physical activities (412).

Increased activities about prevention and treatment of type 2 DM, such as those described during the PAHO Diabetes in the Americas symposium, can be leveraged to increase our understanding of whether strategies designed to target type 2 DM risk factors (i.e., prediabetes, hypertension, and obesity) can actually lead to lower disease risk. As of May 2015, Chile and Mexico had implemented national-level taxes on sodas, and evaluations for these programs are underway (413). Various Latin American countries have set strategies, which have not yet been evaluated, to increase awareness about the harmful effects of transfatty acids (414) and of high salt intake (415–419). Other population-level initiatives include the creation of guidelines for healthful eating and PA; the creation of Ciclovía-Recreovía in Colombia (420), additional training of health care professionals to improve diabetes care, and diabetes screening initiatives in Chile, Argentina, and Honduras, nutrition labeling in Ecuador, and the ban of unhealthful foods in schools in Costa Rica, Perú and Guatemala (418). These new strategies present a unique opportunity to evaluate the process of implementation, the role of stakeholders in their design and implementation, and their eventual impact on anthropometric, lipids, and metabolic indicators or diabetes prevalence and treatment.

Preventing Type 2 DM in Hispanics/Latinos—A Holistic Framework

The epidemiology, etiology, and interventions studies selected for this review provide important insights on the magnitude of the prevalence, the complexity of potential mechanisms of disease, and the approaches toward preventing type 2 DM in Hispanics/Latinos. Based on these insights, it is evident that the successful prevention of type 2 DM in Hispanic/Latino populations in the US and Latin America would need a fundamentally radical transformation. In the era of personalized medicine, this transformation would require a holistic mission and a multidisciplinary approach.

This holistic framework integrates key domains that interact with each other (Figure 2). Within each domain we have identified areas that represent opportunities for enhancing the prevention of type 2 DM in Hispanic/Latino populations—whether as a part of a research program or clinical care intervention. The Hispanic/Latino individual is at the center, and representing the most important element of the framework.

Figure 2

Our understanding of the burden of diabetes (type 1 and type 2) in Hispanic/Latino populations remains insufficient and should be prioritized. The development of effective type 2 DM preventive efforts requires continued surveillance of the burden of disease and its risk factors using disaggregated data on Hispanic/Latino subgroups. Adequate representation of diverse populations would enhance the identification of different phenotypes, and potential disease mediators and interactions. More detailed epidemiologic data at the country level in Latin America are urgently needed.

Consistency and standardization of methodology to assess the prevalence of diabetes in Hispanic/Latino populations would more accurately estimate its prevalence within and among countries and ethnic/heritage groups, and enhance comparison across studies. The need for consistency of methodology and for detailed disaggregated data could be addressed through the creation of repositories of deidentified data, and consortia (including representatives from research study groups, academic centers, medical societies, health authorities, and others) that would strategize the harmonization and/or standardization of methodology for data collection and analysis.

The identification of Hispanics/Latinos and Latin Americans in health-related research is inconsistent. Although the concept of a Hispanic/Latino monolith is slowly changing, the continued use of umbrella terms like “Hispanic” or “Latino” limits the ability of public health and clinical researchers to evaluate and address type 2 DM risk factors that may impact or manifest differently across Hispanic/Latino heritage groups; and this in turns delays the development of effective preventive strategies.

The etiology of type 2 DM is complex, and the research studies discussed in this review demonstrated areas in which further research could be developed. In this regard, it is not completely understood whether the oxidative stress, inflammatory and endothelial changes described in placental and umbilical cord tissue of pregnancies in which the mother had obesity or GDM could be prevented or reverted during pregnancy, and the impact that such reduction would have on the child. At the same time, although GDM has been associated with increased risk for maternal type 2 DM, it is not clear whether GDM increases the mother’s risk for CVD. Determining GDM risk (i.e., a predictive profile) for Hispanic/Latino women might identify those at risk early in pregnancy or before conception, so preventive interventions are tailored and initiated earlier.

Although obesity is associated with increased risk for type 2 DM, the distribution of adipose tissue (i.e., steatosis) has been associated to specific metabolic (421, 422) and cardiac structural abnormalities (423, 424). The study of other type 2 DM risk factors previously mentioned (e.g., sleep-disordered breathing, gut microbiome, environmental exposures) could uncover new mechanisms of disease, which can be turned into additional opportunities for interventions in Hispanic/Latino populations.

As the field of genetics/epigenetics/genomics continues evolving, additional insights on the gene-environment interaction (e.g., chronic stress, environmental endocrine disruptors, other environmental exposures) and the differences in susceptibility to type 2 DM experienced by different Hispanic/Latino heritage groups in the US and Latin America might be uncovered. Thus, the inclusion of Hispanics/Latinos in these research studies needs to improve.

The clinical assessment of Hispanics/Latinos at risk of developing type 2 DM needs to be comprehensive. The medical history needs to account underlying medical, nutritional, physical fitness, emotional, behavioral, cultural, and social factors. A detailed family history will uncover heredity patterns that could be relevant in the decision-making regarding therapy or genetic testing. The individuals’ family dynamics and social network may also uncover dietary habits and values (425–427) that could impact the disease risk, the need for pharmacological therapy, and the effectiveness of the intervention. Socioeconomic factors will influence both type 2 DM risk and the success of any prevention strategy (368–371, 427–431). Access, availability and quality of food; social and family responsibilities, social network and support; stressors; of the built environment, neighborhood safety, transportation, and access to recreational activities; availability and access to health services, health insurance type, and coverage; access to and utilization of medications and medical services; formal education attained and health literacy; and occupation(s), work shift, and occupational safety are some of the factors that will influence the success of the intervention. Incorporating these factors into the clinical assessment could uncover obstacles requiring alternative or additional interventions.

As previously discussed, Hispanics/Latinos at risk of type 2 DM often also have other cardiometabolic factors that increase the risk for developing type 2 DM or CVD (95, 146, 148, 432, 433). While lifestyle intervention would ideally be recommended to every patient at risk, some patients would also need pharmacological therapy to control other cardiometabolic factors (66, 434). Prevention of use of tobacco or its cessation should also be addressed, when applicable.

The difference in prevalence of diabetes across Hispanic/Latino heritage groups presents an opportunity to study potential genetic, biological and environmental interactions that lead to different manifestations of the disease. Deep metabolic phenotyping, (i.e., assessment of glucose homeostasis, insulin sensitivity, insulin secretion, α-cell and β-cell function, adipose tissue distribution) along with a comprehensive clinical assessment (including age, sex, clinical presentation of the disease, detailed medical history, etc.) may uncover important differences or similarities in type 2 DM phenotypes among Hispanic/Latino heritage groups, and biological or health determinants that could influence type 2 DM risk. Given the diversity of the Hispanic/Latino population, the feasibility of such enterprise could be addressed through collaborations like those mentioned above, exploring the use of clinical databases, and creating patient/data registries, among other potential collective efforts.

Type 2 diabetes mellitus preventive strategies have mostly focused on weight reduction, and have produced promising results. However, given the increasing prevalence of obesity in the Hispanic/Latino populations, type 2 DM diabetes and obesity preventive efforts may require even more intensive approaches, perhaps through risk stratification. Preventive efforts focusing on those at higher risk due to age, health status, medications, sedentary lifestyle, family history of type 2 DM or GDM might be different than the strategies for those who have lower susceptibility. The timing of prevention should also be considered. Earlier onset of obesity has been associated with higher risk of developing type 2 DM (173–175), for example. Also, risk stratification should be carefully determined and considering all factors mentioned above. For instance, the DPP reported that over a 10-year follow-up period from randomization, the initial differences in incident diabetes among treatment arms, including the lifestyle intervention, began to narrow (435). Through a retrospective analysis, the investigators examined participants’ susceptibility to type 2 DM, including genetic risk scores (GRSs) (435, 436). The investigators concluded that although clinical and genetic susceptibility could influence risk to develop type 2 DM, GRS alone did not determine the success of the lifestyle intervention; at the highest quartile of GRS, intensive lifestyle intervention was effective at reducing risk (435, 436).

Few behaviors are as closely tied to culture as diet and self-care. What, when, and how much we eat, as well as our notions of health and disease, including whose advice we seek, are firmly grounded in the cultural context which shapes us. It may influence beliefs about what causes diabetes, whether to engage in type 2 DM risk-reduction activities, seek advice regarding the disease, and decide which treatment options are followed. Despite their impact on health and disease management, cultural considerations are often an afterthought in the development and implementation of preventive or treatment interventions targeting type 2 DM in Hispanic/Latino populations. A recent review found only 12 published studies on behavioral interventions aimed at reduction of type 2 DM and specifically designed for Hispanic/Latino adults (380). All interventions were offered in Spanish and took place in community settings, and nine included materials for individuals of low literacy. However, only two included Hispanic/Latino foods or recipes, community input in the intervention content, and addressed cultural beliefs regarding diabetes. Thus, it appears that for most studies, the process of infusing culture into interventions remains at the surface structures (language and setting in which intervention is delivered), without fully incorporating cultural values and elements into intervention messages, materials, design, and implementation (437). Given the evidence that culturally coherent behavioral interventions for diabetes prevention/management among Hispanic/Latino groups are more effective than usual care in improving HbA1c, weight/body mass index, lipid, blood pressure, dietary intake, PA, and diabetes knowledge (438), there is a strong case for ensuring the presence of cultural-competency components in every diabetes-related healthcare service intervention. Cultural competence must be at the core of clinical care and the design and implementation of research studies and large-scale interventions.

Lifestyle intervention studies to prevent type 2 DM in Hispanics/Latinos have mostly been focused on short-term goals of weight reduction, and increasing PA. While they have demonstrated modest success at meeting these goals, follow-up periods have been insufficiently long to demonstrate prevention or delay of type 2 DM. Initiating lifestyle interventions before pregnancy (to prevent GDM, for example), and improving representation of women of various Hispanic/Latino heritage groups, should be seriously considered. Studies focused on children and adolescents could explore the impact of factors, such as maternal health, prenatal care, and child’s development on preventive interventions. Advances in the field will require funding opportunities that allow for longer follow-up periods, permit the examination of interventions and outcomes for different Hispanic/Latino populations, and allow for comparisons of various elements of cultural adaptation. On the other hand, integrating research interventions within established clinical settings or health systems could be resource-efficient way to implement research studies on type 2 DM prevention, including the follow-up of research study participants.

Quality of life and savings in disability-adjusted life years resulting from delaying the onset of type 2 DM should be quantified and qualified, especially among high-risk populations like Hispanics/Latinos. Also, the evaluation of type 2 DM risk prevention in multilevel community studies to prevent childhood obesity (331, 332), coupled with mass media campaigns to increase awareness of type 2 DM prevention (336, 439), and other risk factors for diabetes, is warranted.

The success of large culturally tailored interventions, such as those modeled after the DPP, underscore the promise that such interventions might result in improved quality of life, higher productivity, and reduced morbidity and mortality for Hispanic/Latino populations. However, it is critical to remain aware that the vast heterogeneity in the Hispanic/Latino population requires clinicians and researchers alike to avoid relying on vague and largely unexamined concepts, such as familism and marianism without first verifying their relevance in the population of interest. Often, the uncritical acceptance of these values as omnipresent in individuals of Hispanic/Latino origin results in the automatic assumptions that, for example, interventions must be family based. Upon closer examination, studies have found that the Hispanic family unit is much more complex, and less unconditionally supportive, than it is often assumed to be, and in many cases, some Hispanic/Latino women prefer women-only group interventions without the inhibiting presence of family members, children, or spouses (440, 441).

In both clinical and research programs, engagement of stakeholders, not only including the patient population and the healthcare provider team, but also administrative clinic and research staff, is critical for the success of health-promotion interventions. A bidirectional communication style, from clinicians/investigators to patients and community, is necessary to ensure the cultural coherence, accessibility, and sustainability of a program. Individuals who are thoroughly competent in the cultural, socioeconomic, and even geographic context of the target population can navigate cultural nuances of these heterogeneous populations and provide invaluable guidance in the design and implementation of both large- and small-scale preventive and treatment efforts.

Upon designing a research project or implementing a clinical program to prevent type 2 DM in Hispanics/Latinos in the US and in Latin America, other challenges need to be acknowledged. Insufficient institutional (government, academic, etc.) interest or commitment, lack of public awareness on the importance of prevention, insufficient financial and human resources, and political issues are some of the challenges faced across the continent (442–444). Whereas out of the scope of this review, proposed models of an international collaborative initiative (442) and of an implementation cycle and a translatability scale for identifying and implementing effective solutions to address the rising burden of chronic diseases in low-middle income countries, specifically CVD (444), might set the stage for future type 2 DM prevention initiatives in the continent.

The progressive and sustained increase in type 2 DM among Hispanics/Latinos is a clear indicator that preventive efforts need to be seriously and urgently reframed. This will require a better understanding of the extent and etiology of the disease, creating solutions through multidisciplinary approaches, and a fundamentally radical transformation in our priorities as individuals and as communities.

Disclaimer

The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the US Department of Health and Human Services.

References

• 1

  García-MárquezG. No one writes to the colonel. 1st ed. In: García-MárquezG, editor. Collected Novellas. New York, NY: Harper Perennial (1991). 152 p.

  • Google Scholar
  • View reference in article

• 2

  Jacome RocaA. Diabetes en Colombia: Recuento Histórico y Bibliográfico. (2013). Available from: http://encolombia.com/medicina/revistas-medicas/d-diabetes/d22/historia-y-bibliografia/

  • Google Scholar
  • View reference in article

• 3

  ScolpiniV. Historia de la diabetes en el Uruguay. Arch Pediatr Urug (1982) 53:245–59.

  • Google Scholar
  • View reference in article

• 4

  World Health Organization. The Top 10 Causes of Death. (2017). Available from: http://www.who.int/mediacentre/factsheets/fs310/en/

  • Google Scholar
  • View reference in article

• 5

  United States Census Bureau. Profile America Facts for Features, CB16-FF.16 Hispanic Heritage Month. (2016). Available from: http://census.gov/newsroom/facts-for-features/2016/cb16-ff16.html

  • Google Scholar
  • View reference in article

• 6

  ColbySLOrtmanJM. Projections of the Size and Composition of the US Population: 2014-2060, Current Population Reports 2015; P25-1143. Washington, DC: US Census Bureau (2014).

  • Google Scholar
  • View reference in article

• 7

  PattenE. The Nation’s Latino Population Is Defined by Its Youth. Pew Research Center, Hispanic Trends (2016). Available from: http://www.pewhispanic.org/2016/04/20/the-nations-latino-population-is-defined-by-its-youth/

  • Google Scholar
  • View reference in article

• 8

  MenkeACasagrandeSSGeissLCowieCC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA (2015) 314:1021–9.10.1001/jama.2015.10029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 9

  Alegre-DíazJHerringtonWLópez-CervantesMGnauticLRamírezRHillMet alDiabetes and cause-specific mortality in Mexico City. N Engl J Med (2016) 375:1961–71.10.1056/NEJMoa1605368

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 10

  Colón-RamosURodríguez-AyusoIGebrekristosHTRoessAPérezCMSimonsenL. Transnational mortality comparisons between archipelago and mainland Puerto Ricans. J Immigr Minor Health (2017) 19:1009–17.10.1007/s10903-016-0448-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 11

  FlegalKMEzzatiTMHarrisMIHaynesSGJuarezRZKnowlerWCet alPrevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care (1991) 14:628–38.10.2337/diacare.14.7.628

  • CrossRef
  • Google Scholar
  • View reference in article

• 12

  SchneidermanNLlabreMCowieCCBarnhartJCarnethonMGalloLCet alPrevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care (2014) 37:2233–9.10.2337/dc13-2939

  • CrossRef
  • Google Scholar
  • View reference in article

• 13

  Avilés-SantaMLSchneidermanNSavagePJKaplanRCTengYPérezCMet alIdentifying probable diabetes mellitus among Hispanics/Latinos from four U.S. cities: findings from the Hispanic Community Health Study/Study of Latinos. Endocr Pract (2016) 22:1151–60.10.4158/EP151144.OR

  • CrossRef
  • Google Scholar
  • View reference in article

• 14

  HumesKRJonesNARamirezRR. Overview of Race and Hispanic Origin: 2010; 2010 Census Briefs. (2011). Available from: https://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf

  • Google Scholar
  • View reference in article

• 15

  Interim Report to the Office of Management and Budget. Review of Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity. (2017). Available from: https://www.whitehouse.gov/sites/whitehouse.gov/files/briefing-room/presidential-actions/related-omb-material/r_e_iwg_interim_report_022417.pdf

  • Google Scholar
  • View reference in article

• 16

  EnnisSRRíos-VargasMAlbertNG. The Hispanic Population: 2010, 2010 Census Briefs. Suitland, MD: U.S. Department of Commerce Economics and Statistics Administration, U.S. Census Bureau (2011).

  • Google Scholar
  • View reference in article

• 17

  LopezMH. Hispanic or Latino? Many Don’t Care, Except in Texas. Pew Research Center (2013). Available from: http://www.pewresearch.org/fact-tank/2013/10/28/in-texas-its-hispanic-por-favor/

  • Google Scholar
  • View reference in article

• 18

  LopezMH. Hispanic Identity. Pew Research Center Hispanic Trends (2013). Available from: http://www.pewhispanic.org/2013/10/22/3-hispanic-identity/

  • Google Scholar
  • View reference in article

• 19

  Diccionario de la Real Academia Española de la Lengua. (2017). Available from: http://lema.rae.es/dpd/?key=hispanoamerica

  • Google Scholar
  • View reference in article

• 20

  LegorburuJ. Lengua y Literatura II. Madrid, Spain: Ediciones S.M. Madrid (1980). p. 24–6.

  • Google Scholar
  • View reference in article

• 21

  U.S. Census Bureau. American Community Survey 1-Year Estimates. (2015). Available from: https://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml

  • Google Scholar
  • View reference in article

• 22

  SteplerRBrownA. Statistical Portrait of Hispanics in the United States. (2017). Available from: http://www.pewhispanic.org/2016/04/19/statistical-portrait-of-hispanics-in-the-united-states-trends/

  • Google Scholar
  • View reference in article

• 23

  United States Census Bureau. Facts for Figures: Hispanic Heritage Month 2016. (2016). Release Number: CB16-FF.16.

  • Google Scholar
  • View reference in article

• 24

  OrtmanJMGuarnieriCE. United States Population Projections: 2000-2050. National Population Projections (2009). Available from: https://www.census.gov/library/working-papers/2009/demo/us-pop-proj-2000-2050.html

  • Google Scholar
  • View reference in article

• 25

  U.S. Census Bureau American FactFinder. 2011-2015 American Community Survey 5-Year Estimates. U.S. Census Bureau (2017). Available from: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_15_5YR_S1501&src=pt

  • Google Scholar
  • View reference in article

• 26

  ProctorBDSemegaJLKollarMA. U.S. Census Bureau, Current Population Reports, P60-256(RV), Income and Poverty in the United States: 2015. Washington, DC: U.S. Government Printing Office (2016).

  • Google Scholar
  • View reference in article

• 27

  SmithJMedaliaC. US Census Bureau, Current Population Reports, P 60-253 Health Insurance Coverage in the United States: 2014. Washington, DC: US Government Printing Office (2015).

  • Google Scholar
  • View reference in article

• 28

  CohenRAMartinezME. Health Insurance Coverage: Early Release of Estimates from the National Health Interview Survey, January-March 2014. Atlanta: National Center for Health Statistics (2014). Available from: https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201409.pdf

  • Google Scholar
  • View reference in article

• 29

  PenedoFJYanezBCastañedaSFGalloLWortmanKGouskovaNet alSelf-reported cancer prevalence among Hispanics in the US: results from the Hispanic Community Health Study/Study of Latinos. PLoS One (2016) 11:e0146268.10.1371/journal.pone.0146268

  • CrossRef
  • Google Scholar
  • View reference in article

• 30

  United Nations Department of Economic and Social Affairs/Population Division. World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. New York (2015). Available from: https://esa.un.org/unpd/wpp/publications/

  • Google Scholar
  • View reference in article

• 31

  CEPAL (Comisión Económica para América Latina y el Caribe/Economic Commission for Latin America and the Caribbean). Anuario estadístico de America Latina y El Caribe/Statistical Yearbook for Latin America and the Caribbean. (2017). Available from: https://www.cepal.org/en/publications/type/anuario-estadistico-america-latina-caribe-statistical-yearbook-latin-america-and

  • Google Scholar
  • View reference in article

• 32

  U.S. Commission on Civil Rights. Counting the Forgotten: The 1970 Census Count of Persons of Spanish Speaking Background in the United States. (2017). Available from: https://www.law.umaryland.edu/marshall/usccr/documents/cr12sp22970.pdf

  • Google Scholar
  • View reference in article

• 33

  MoyCS. Determining ethnic origin in an interview survey: problems and recommendations. Public Health Rep (1977) 92:414–20.

  • Google Scholar
  • View reference in article

• 34

  GoldbergB. Tuberculosis in racial types with special reference to Mexicans. Am J Pub Health (1929) 19:274–84.10.2105/AJPH.19.3.274

  • CrossRef
  • Google Scholar
  • View reference in article

• 35

  GreggR. Medical examination and vaccination of farm laborers recruited from Mexico. Public Health Rep (1950) 65:807–9.10.2307/4587381

  • CrossRef
  • Google Scholar
  • View reference in article

• 36

  KeissmanJJ. The curandero’s apprentice: a therapeutic integration of folk and medical care. Am J Psychiatry (1975) 132:81–3.10.1176/ajp.132.1.81

  • CrossRef
  • Google Scholar
  • View reference in article

• 37

  GarrisonV. Support systems of schizophrenic and nonschizophrenic Puerto Rican migrant women in New York City. Schizophr Bull (1978) 4:561–96.10.1093/schbul/4.4.561

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 38

  SuffetFBrotmanR. Employment and social disability among opiate addicts. Am J Drug Alcohol Abuse (1976) 3:387–95.10.3109/00952997609014281

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 39

  KlineLY. Some factors in the psychiatric treatment of Spanish-Americans. Am J Psychiatry (1969) 125:1674–81.10.1176/ajp.125.12.1674

  • CrossRef
  • Google Scholar
  • View reference in article

• 40

  MirowskyJIIRossCE. Minority status, ethnic culture, and distress: a comparison of blacks, whites, Mexicans, and Mexican Americans. AJS (1980) 86:479–95.

  • Google Scholar
  • View reference in article

• 41

  KlermanLVJonesJGHullMC. Puerto Ricans in a small U.S. city. Public Health Rep (1966) 81:369–76.10.2307/4592720

  • CrossRef
  • Google Scholar
  • View reference in article

• 42

  HoppeSKLeonRL. Coping in the barrio: case studies of Mexican-American families. Child Psychiatry Hum Dev (1977) 7:264–75.10.1007/BF01433935

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 43

  KuttnerREMailanderJC. Serum pepsinogen in migrant Mexicans and stressed Caucasians. J Natl Med Assoc (1965) 57:109–11.

  • Google Scholar
  • View reference in article

• 44

  DrakeGCarpenterCMDunnJE. Further studies on the frequency of achlorydria among Mexicans in Los Angeles. J Natl Cancer Inst (1962) 28:853–7.

  • Google Scholar
  • View reference in article

• 45

  CarmelRJohnsonCS. Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N Engl J Med (1978) 298:647–50.10.1056/NEJM197803232981203

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 46

  SchenkEAKilpsteinFATomasiniJT. Morphologic characteristics of jejunal biopsies from asymptomatic Haitians and Puerto Ricans. Am J Clin Nutr (1972) 25:1080–3.

  • Google Scholar
  • View reference in article

• 47

  WinsbergGRSonnenscheinEDyerARSchnadigVBonillaE. Prevalence of intestinal parasites in Latino residents of Chicago. Am J Epidemiol (1975) 102:526–32.10.1093/oxfordjournals.aje.a112190

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 48

  MascolaLPelosiRBlountJHBinkinNJAlexanderCECatesWJr. Congenital syphilis. Why is it still occurring?JAMA (1984) 5:1719–22.

  • Pubmed Abstract
  • Google Scholar
  • View reference in article

• 49

  VandowJE. Venereal disease among Puerto Ricans in New York City. Public Health Rep (1955) 70:1242–6.10.2307/4589333

  • CrossRef
  • Google Scholar
  • View reference in article

• 50

  HernandezA. Chicanas and the issue of involuntary sterilization: reforms needed to protect inform consent. Chicano Law Rev (1976) 3:3–37.

  • Google Scholar
  • View reference in article

• 51

  DawberTRMeadorsGFMooreFE. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health (1951) 41:279–81.10.2105/AJPH.41.3.279

  • CrossRef
  • Google Scholar
  • View reference in article

• 52

  DawberTRMooreFEMannGV. Coronary heart disease in the Framingham study. Am J Public Health Nations Health (1957) 47:4–24.10.2105/AJPH.47.4_Pt_2.4

  • CrossRef
  • Google Scholar
  • View reference in article

• 53

  DawberTRKannelWBRevotskieNStokesJIIIKaganAGordonT. Some factors associated with the development of coronary heart disease: six years’ follow-up experience in the Framingham study. Am J Public Health Nations Health (1959) 49:1349–56.10.2105/AJPH.49.10.1349

  • CrossRef
  • Google Scholar
  • View reference in article

• 54

  Cruz-VidalMCostasRGarcia-PalmieriMRSorliePDHertzmarkE. Factors related to diabetes mellitus in Puerto Rican men. Diabetes (1979) 28:300–7.10.2337/diab.28.4.300

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 55

  Cruz-VidalMGarcía-PalmieriMRCostasRSorliePDHavlikRJ. Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program. Diabetes Care (1983) 6:556–61.10.2337/diacare.6.6.556

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 56

  GaskillSPAllenCRGarzaVGonzalesJLWaldropRH. Cardiovascular risk factors in Mexican Americans in Laredo, Texas: I. Prevalence of overweight and diabetes and distributions of serum lipids. Am J Epidemiol (1981) 113:546–55.10.1093/oxfordjournals.aje.a113131

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 57

  GunbyP. San Antonio Heart Study compares ethnic groups. JAMA (1980) 244:225.10.1001/jama.244.3.225a

  • CrossRef
  • Google Scholar
  • View reference in article

• 58

  SternMPPughJAGaskillSPHazudaHP. Knowledge, attitudes, and behavior related to obesity and dieting in Mexican Americans and Anglos: the San Antonio Heart Study. Am J Epidemiol (1982) 115:917–28.10.1093/oxfordjournals.aje.a113379

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 59

  DelgadoJLJohnsonCLTreviñoFM. Hispanic health nutrition and examination survey: methodological considerations. Am J Public Health (1990) 80(Suppl):6–10.10.2105/AJPH.80.Suppl.6

  • CrossRef
  • Google Scholar
  • View reference in article

• 60

  CrespoCLoriaCBurtV. Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey. Public Health Rep (1996) 111(Suppl 2):7–10.

  • Pubmed Abstract
  • Google Scholar
  • View reference in article

• 61

  HammanRFMarshallJABaxterJKahnLBMayerEJOrleansMet alMethods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population, the San Luis Valley Diabetes Study. Am J Epidemiol (1989) 129:295–311.10.1093/oxfordjournals.aje.a115134

  • CrossRef
  • Google Scholar
  • View reference in article

• 62

  Behavioral Risk Factor Surveillance System. (2017). Available from: https://www.cdc.gov/brfss/

  • Google Scholar
  • View reference in article

• 63

  National Center for Health Statistics. National Health and Nutrition Examination Survey. (2017). Available from: https://www.cdc.gov/nchs/nhanes/

  • Google Scholar
  • View reference in article

• 64

  SorliePDAvilés-SantaMLWassertheil-SmollerSKaplanRCDaviglusMLGiachelloAet alDesign and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 20:629–41.10.1016/j.annepidem.2010.03.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 65

  LaVangeLMKalsbeekWSorliePDAvilés-SantaMLKaplanRCBarnhartJet alSample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 20:642–9.10.1016/j.annepidem.2010.05.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar
  • View reference in article

• 66

  American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care (2017) 40(Suppl 1):S11–24.10.2337/dc17-S005

  • CrossRef
  • Google Scholar
  • View reference in article

• 67

  World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. World Health Organization (2011). Available from: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1

  • Google Scholar

• 68

  World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. World Health Organization (2006). Available from: http://apps.who.int/iris/bitstream/10665/43588/1/9241594934_eng.pdf

  • Google Scholar

• 69

  HanisCLFerrellREBartonSAAguilarLGarza-IbarraATullochBRet alDiabetes among Mexican Americans in Starr County, Texas. Am J Epidemiol (1983) 118:659–72.10.1093/oxfordjournals.aje.a113677

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 70

  SametJMCoultasDBHowardCASkipperBJHanisCL. Diabetes, gallbladder disease, obesity, and hypertension among Hispanics in New Mexico. Am J Epidemiol (1988) 128:1302–11.10.1093/oxfordjournals.aje.a115083

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 71

  HammanRFMayerEJMoo-YoungGAHildebrandtWMarshallJABaxterJ. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes (1989) 38:1231–7.10.2337/diab.38.10.1231

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 72

  MitchellBDSternMPHaffnerSMHazudaHPPattersonJK. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol (1990) 131:423–33.10.1093/oxfordjournals.aje.a115517

  • CrossRef
  • Google Scholar

• 73

  HaddockLde ContyIT. Prevalence rates for diabetes mellitus in Puerto Rico. Diabetes Care (1991) 14:676–84.10.2337/diacare.14.7.676

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 74

  SternMPGonzalezCMitchellBDVillalpandoEHaffnerSMHazudaHP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes (1992) 41:484–92.10.2337/diab.41.4.484

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 75

  WilliamsDECadwellBLChengYJCowieCCGreggEWGeissLSet alPrevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics (2005) 116:1122–6.10.1542/peds.2004-2001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 76

  LeeJMOkumuraMJDavisMMHermanWHGurneyJG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care (2006) 29:2427–32.10.2337/dc06-0709

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 77

  IoannouGNBrysonCLBoykoEJ. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes. J Diabetes Complications (2007) 21:363–70.10.1016/j.jdiacomp.2006.07.005

  • CrossRef
  • Google Scholar

• 78

  AllisonMABudoffMJWongNDBlumenthalRSSchreinerPJCriquiMH. Prevalence of and risk factors for subclinical cardiovascular disease in selected US Hispanic ethnic groups: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2008) 167:962–9.10.1093/aje/kwm402

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 79

  CowieCCRustKFFordESEberhardtMSByrd-HoltDDLiCet alFull accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2009) 32:287–94.10.2337/dc08-1296

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 80

  LiCFordESZhaoGMokdadAH. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care (2009) 32:342–7.10.2337/dc08-1128

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 81

  DerbyCAWildmanRPMcGinnAPGreenRRPolotskyAJRamKTet alCardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women’s Health Across the Nation. Ethn Dis (2010) 20:396–402.

  • Pubmed Abstract
  • Google Scholar

• 82

  Díaz-ApodacaBAEbrahimSMcCormackVde CosíoFGRuiz-HolguínR. Prevalence of type 2 diabetes and impaired fasting glucose: cross-sectional study of multiethnic adult population at the United States-Mexico border. Rev Panam Salud Publica (2010) 28:174–81.10.1590/S1020-49892010000900007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 83

  Centers for Disease Control and Prevention (CDC). Increasing prevalence of diagnosed diabetes – United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep (2012) 61:918–21.

  • Google Scholar

• 84

  DaviglusMLTalaveraGAAvilés-SantaMLAllisonMCaiJCriquiMHet alPrevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA (2012) 308:1775–84.10.1001/jama.2012.14517

  • CrossRef
  • Google Scholar

• 85

  HuntKJGebregziabherMEgedeLE. Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008. J Gen Intern Med (2012) 27:893–900.10.1007/s11606-012-2023-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 86

  RodriguezFHicksLSLopezL. Association of acculturation and country of origin with self-reported hypertension and diabetes in a heterogeneous Hispanic population. BMC Public Health (2012) 12:768.10.1186/1471-2458-12-768

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 87

  BullardKMSaydahSHImperatoreGCowieCCGreggEWGeissLSet alSecular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care (2013) 36:2286–93.10.2337/dc12-2563

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 88

  DabeleaDMayer-DavisEJSaydahSImperatoreGLinderBDiversJet alPrevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA (2014) 311:1778–86.10.1001/jama.2014.3201

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 89

  PettittDJTaltonJDabeleaDDiversJImperatoreGLawrenceJMet alPrevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care (2014) 37:402–8.10.2337/dc13-1838

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 90

  SelvinEParrinelloCMSacksDBCoreshJ. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 160:517–25.10.7326/M13-2411

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 91

  Arroyo-JohnsonCMinceyKDAckermannNMilamLGoodmanMSColditzGA. Racial and ethnic heterogeneity in self-reported diabetes prevalence trends across Hispanic subgroups, National Health Interview Survey, 1997-2012. Prev Chronic Dis (2016) 13:E10.10.5888/pcd13.150260

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 92

  IsasiCRParrinelloCMAyalaGXDelamaterAMPerreiraKMDaviglusMLet alSex differences in cardiometabolic risk factors among Hispanic/Latino youth. J Pediatr (2016) 176:121–7.e1.10.1016/j.jpeds.2016.05.037

  • CrossRef
  • Google Scholar

• 93

  HanisCLRedlineSCadeBEBellGICoxNJBelowJEet alBeyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas. Cardiovasc Diabetol (2016) 15:86.10.1186/s12933-016-0405-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 94

  MenkeACasagrandeSCowieCC. Prevalence of diabetes in adolescents aged 12 to 19 years in the United States, 2005-2014. JAMA (2016) 316:344–5.10.1001/jama.2016.8544

  • CrossRef
  • Google Scholar

• 95

  Avilés-SantaMLPérezCMSchneidermanNSavagePJKaplanRCTengYet alDetecting prediabetes among Hispanics/Latinos from diverse heritage groups: does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos. Prev Med (2017) 95:110–8.10.1016/j.ypmed.2016.12.009

  • CrossRef
  • Google Scholar

• 96

  Stark CasagrandeSFradkinJESaydahSHRustKFCowieCC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care (2013) 36:2271–9.10.2337/dc12-2258

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 97

  SchneidermanNLlabreMMChirinosDATengYCaiJCowieCCet alDiversity in diabetes status and cardiovascular disease in the Longitudinal Hispanic Community Health Study. Circulation (2017) 135(Suppl 1):A075.

  • Google Scholar

• 98

  MenkeACasagrandeSSAvilés-SantaMLCowieCC. Factors associated with being unaware of having diabetes. Diabetes Care (2017) 40:e55–6.10.2337/dc16-2626

  • CrossRef
  • Google Scholar

• 99

  HaffnerSMHazudaHPMitchellBDPattersonJKSternMP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care (1991) 14:102–8.10.2337/diacare.14.7.665

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 100

  BaxterJHammanRFLopezTKMarshallJAHoagSSwensonCJ. Excess incidence of known non-insulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado. Ethn Dis (1993) 3:11–21.

  • Google Scholar

• 101

  BurkeJPWilliamsKGaskillSPHazudaHPHaffnerSMSternMP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med (1999) 159:1450–6.10.1001/archinte.159.13.1450

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 102

  BurkeJPWilliamsKHaffnerSMVillalpandoCGSternMP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care (2001) 24:1573–8.10.2337/diacare.24.9.1573

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 103

  LawrenceJMMayer-DavisEJReynoldsKBeyerJPettittDJD’AgostinoRBJret alDiabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for diabetes in youth study. Diabetes Care (2009) 32(Suppl 2):S123–32.10.2337/dc09-S204

  • CrossRef
  • Google Scholar

• 104

  FuhrmanBJSmitECrespoCJGarcia-PalmieriMR. Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program. Public Health Nutr (2009) 12:842–8.10.1017/S1368980008003303

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 105

  TabaeiBPChamanySDriverCRKerkerBSilverL. Incidence of self-reported diabetes in New York city, 2002, 2004, and 2008. Prev Chronic Dis (2012) 9:110320.10.5888/pcd9.110320

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 106

  Mayer-DavisEJLawrenceJMDabeleaDDiversJIsomSDolanLet alIncidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med (2017) 376:1419–29.10.1056/NEJMoa1610187

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 107

  BerkowitzGSLapinskiRHWeinRLeeD. Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol (1992) 135:965–73.10.1093/oxfordjournals.aje.a116408

  • CrossRef
  • Google Scholar

• 108

  SolomonCGWillettWCCareyVJRich-EdwardsJHunterDJColditzGAet alA prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 278:1078–83.10.1001/jama.1997.03550130052036

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 109

  FerraraAKahnHSQuesenberryCRileyCHeddersonMM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol (2004) 103:526–33.10.1097/01.AOG.0000113623.18286.20

  • CrossRef
  • Google Scholar

• 110

  SavitzDAJanevicTMEngelSMKaufmanJSHerringAH. Ethnicity and gestational diabetes in New York city, 1995-2003. BJOG (2008) 115:969–78.10.1111/j.1471-0528.2008.01763.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 111

  ChuSYAbeKHallLRKimSYNjorogeTQinC. Gestational diabetes mellitus: all Asians are not alike. Prev Med (2009) 49:265–8.10.1016/j.ypmed.2009.07.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 112

  KimSYSaraivaCCurtisMWilsonHGTroyanJSharmaAJ. Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009. Am J Public Health (2013) 103:e65–72.10.2105/AJPH.2013.301469

  • CrossRef
  • Google Scholar

• 113

  BardenheierBHImperatoreGGilboaSMGeissLSSaydahSHDevlinHMet alTrends in gestational diabetes among hospital deliveries in 19 U.S. States, 2000-2010. Am J Prev Med (2015) 49:12–9.10.1016/j.amepre.2015.01.026

  • CrossRef
  • Google Scholar

• 114

  BardenheierBHImperatoreGDevlinHMKimSYChoPGeissLS. Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010. Am J Prev Med (2015) 48:154–61.10.1016/j.amepre.2014.08.031

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 115

  MalerbiDAFrancoLJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care (1992) 15:1509–16.10.2337/diacare.15.11.1509

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 116

  OliveiraJEMilechAFrancoLJ. The prevalence of diabetes in Rio de Janeiro, Brazil. The Cooperative Group for the Study of Diabetes Prevalence in Rio De Janeiro. Diabetes Care (1996) 19:663–6.10.2337/diacare.19.6.663

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 117

  BarcelóADarocaMCRiberaRDuarteEZapataAVohraM. Diabetes in Bolivia. Rev Panam Salud Publica (2001) 10:318–23.

  • Pubmed Abstract
  • Google Scholar

• 118

  TorquatoMTMontenegro JúniorRMVianaLAde SouzaRALannaCMLucasJCet alPrevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. Sao Paulo Med J (2003) 121:224–30.10.1590/S1516-31802003000600002

  • CrossRef
  • Google Scholar

• 119

  Aguilar-SalinasCAVelazquez MonroyOGómez-PérezFJGonzalez ChávezAEsquedaALMolina CuevasVet alCharacteristics of patients with type 2 diabetes in México: results from a large population-based nationwide survey. Diabetes Care (2003) 26:2021–6.10.2337/diacare.26.7.2021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 120

  SeredayMSGonzalezCGiorginiDDe LoredoLBraguinskyJCobeñasCet alPrevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab (2004) 30:335–9.10.1016/S1262-3636(07)70125-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 121

  Sánchez-CastilloCPVelásquez-MonroyOLara-EsquedaABerberASepulvedaJTapia-ConyerRet alDiabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr (2005) 8:53–60.10.1079/PHN2004659

  • CrossRef
  • Google Scholar

• 122

  AlbalaCLebrãoMLLeón DíazEMHam-ChandeRHennisAJPalloniAet alThe health, well-being, and aging (“SABE”) survey: methodology applied and profile of the study population. Rev Panam Salud Publica (2005) 17:307–22.10.1590/S1020-49892005000500003

  • CrossRef
  • Google Scholar

• 123

  BarcelóAPeláezMRodriguez-WongLPastor-ValeroM. The prevalence of diagnosed diabetes among the elderly of seven cities in Latin America and the Caribbean: the health wellbeing and aging (SABE) project. J Aging Health (2006) 18:224–39.10.1177/0898264305285728

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 124

  BarcelóAGreggEWPastor-ValeroMRoblesSC. Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean. Diabetes Res Clin Pract (2007) 78:418–27.10.1016/j.diabres.2007.06.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 125

  MeaneyELara-EsquedaACeballos-ReyesGMAsbunJVelaAMartínez-MarroquínYet alCardiovascular risk factors in the urban Mexican population: the FRIMEX study. Public Health (2007) 121:378–84.10.1016/j.puhe.2006.11.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 126

  Medina-LezamaJMorey-VargasOLZea-DíazHBolaños-SalazarJFCorrales-MedinaFCuba-BustinzaCet alPrevalence of lifestyle-related cardiovascular risk factors in Peru: the PREVENCION study. Rev Panam Salud Publica (2008) 24:169–79.10.1590/S1020-49892008000900003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 127

  CapilheiraMFSantosISAzevedoMRReichertFF. Risk factors for chronic non-communicable diseases and the CARMEN initiative: a population-based study in the south of Brazil. Cad Saúde Pública (2008) 24:2767–74.10.1590/S0102-311X2008001200005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 128

  SchargrodskyHHernández-HernándezRChampagneBMSilvaHVinuezaRSilva AyçaguerLCet alCARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med (2008) 121:58–65.10.1016/j.amjmed.2007.08.038

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 129

  EscobedoJBuitrónLVVelascoMFRamírezJCHernándezRMacchiaAet alHigh prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA study. Diabet Med (2009) 26:864–71.10.1111/j.1464-5491.2009.02795.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 130

  Kuri-MoralesPEmbersonJAlegre-DíazJTapia-ConyerRCollinsRPetoRet alThe prevalence of chronic diseases and major disease risk factors at different ages among 150,000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health (2009) 9:9.10.1186/1471-2458-9-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 131

  BurrowsRALeivaLBWeisstaubGLeraLMAlbalaCBBlancoEet alHigh HOMA-IR, adjusted for puberty, relates to the metabolic syndrome in overweight and obese Chilean youths. Pediatr Diabetes (2011) 12:212–8.10.1111/j.1399-5448.2010.00685.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 132

  BautistaLECasasJPHerreraVMMirandaJJPerelPPichardoRet alThe Latin American consortium of studies in obesity (LASO). Obes Rev (2009) 10:364–70.10.1111/j.1467-789X.2009.00591.x

  • CrossRef
  • Google Scholar

• 133

  MirandaJJHerreraVMChirinosJAGómezLFPerelPPichardoRet alMajor cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American consortium of studies in obesity (LASO). PLoS One (2013) 8:e54056.10.1371/journal.pone.0054056

  • CrossRef
  • Google Scholar

• 134

  AquinoEMBarretoSMBensenorIMCarvalhoMSChorDDuncanBBet alBrazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol (2012) 175:315–24.10.1093/aje/kwr294

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 135

  SchmidtMIHoffmanJFde Fátima Sander DinizMLotufoPAGriepRHBensenorIMet alHigh prevalence of diabetes and intermediate hyperglycemia – the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr (2014) 6:123.10.1186/1758-5996-6-123

  • CrossRef
  • Google Scholar

• 136

  RubinsteinALIrazolaVECalandrelliMElorriagaNGutierrezLLanasFet alMultiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay. Int J Cardiol (2015) 183:82–8.10.1016/j.ijcard.2015.01.062

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 137

  McDonald PossoAJBradshaw MezaRAMendoza MoralesEAJaenYCumbrera OrtegaAMendoza PosadaEJ. Diabetes in Panama: epidemiology, risk factors, and clinical management. Ann Glob Health (2015) 81:754–64.10.1016/j.aogh.2015.12.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 138

  ShenJKondalDRubinsteinAIrazolaVGutierrezLMirandaJJet alA multiethnic study of pre-diabetes and diabetes in LMIC. Glob Heart (2016) 11:61–70.10.1016/j.gheart.2015.12.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 139

  Bernabé-OrtizACarrillo-LarcoRMGilmanRHMieleCHCheckleyWWellsJCet alGeographical variation in the progression of type 2 diabetes in Peru: the CRONICAS cohort study. Diabetes Res Clin Pract (2016) 121:135–45.10.1016/j.diabres.2016.09.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 140

  AschnerPAguilar-SalinasCAguirreLFrancoLGagliardinoJJde LapertosaSGet alDiabetes in South and Central America: an update. Diabetes Res Clin Pract (2014) 103:238–43.10.1016/j.diabres.2013.11.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 141

  International Diabetes Federation. Diabetes Atlas. 7th ed. Brussels, Belgium (2015). Available from: www.diabetesatlas.org

  • Google Scholar

• 142

  SchmidtMIDuncanBBReicheltAJBranchteinLMatosMCCosta e FortiAet alGestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care (2001) 24:1151–5.10.2337/diacare.24.7.1151

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 143

  González-VillalpandoCDávila-CervantesCAZamora-MacorraMTrejo-ValdiviaBGonzález-VillalpandoME. Incidence of type 2 diabetes in Mexico: results of the Mexico City diabetes study after 18 years of follow-up. Salud Publica Mex (2014) 56:11–7.10.21149/spm.v56i1.7318

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 144

  FlegalKMKruszon-MoranDCarrollMDFryarCDOgdenCL. Trends in obesity among adults in the United States, 2005-2014. JAMA (2016) 315:2284–91.10.1001/jama.2016.6458

  • CrossRef
  • Google Scholar

• 145

  OgdenCLCarrollMDLawmanHGFryarCDKruszonDKitBKet alTrends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA (2016) 315:2292–9.10.1001/jama.2016.6361

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 146

  HeissGSnyderMLTengYSchneidermanNLlabreMMCowieCet alPrevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care (2014) 37:2391–9.10.2337/dc13-2505

  • CrossRef
  • Google Scholar

• 147

  PérezCMSánchezHOrtizAP. Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico. J Community Health (2013) 38:1140–6.10.1007/s10900-013-9726-5

  • CrossRef
  • Google Scholar

• 148

  PérezCMOrtizAPGuzmánMSuárezE. Distribution of the metabolic syndrome in adults living in the San Juan Metropolitan area of Puerto Rico. P R Health Sci J (2012) 31:114–22.

  • Google Scholar

• 149

  BenseñorIMGuolartACSantosISBittencourtMSPereiraACSantosRDet alAssociation between a healthy cardiovascular profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Am Heart J (2016) 174:51–9.10.1016/j.ahj.2015.12.018

  • CrossRef
  • Google Scholar

• 150

  RiveraJADe CossioTGPedrazaLSAburtoTCSánchezTGMartorellR. Childhood and adolescent overweight and obesity in Latin America: a systematic review. Lancet Diabetes Endocrinol (2014) 2:321–32.10.1016/S2213-8587(13)70173-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 151

  Hernández-CorderoSCuevas-NasuLMorán-RuánMCMéndez-Gómez HumaránIAvila-ArcosMARivera-DommarcoJA. Overweight and obesity in Mexican children and adolescents during the last 25 years. Nutr Diabetes (2017) 7:e247.10.1038/nutd.2016.52

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 152

  ParraDCIannottiLGómezLFPachónHHaire-JoshuDSarmientoOLet alThe nutrition transition in Colombia over a decade: a novel household classification system of anthropometric measures. Arch Public Health (2015) 73:12.10.1186/s13690-014-0057-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 153

  GuoFHeDZhangWWaltonRG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999-2010. J Am Coll Cardiol (2012) 60:599–606.10.1016/j.jacc.2012.04.026

  • CrossRef
  • Google Scholar

• 154

  SorliePDAllisonMAAvilés-SantaMLCaiJDaviglusMLHowardAGet alPrevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens (2014) 27:793–800.10.1093/ajh/hpu003

  • CrossRef
  • Google Scholar

• 155

  Hernández-HernándezRSilvaHVelascoMPellegriniFMacchiaAEscobedoJet alHypertension in seven Latin American cities: the cardiovascular risk factor multiple evaluation in Latin America (CARMELA) study. J Hypertens (2010) 28:24–34.10.1097/HJH.0b013e328332c353

  • CrossRef
  • Google Scholar

• 156

  CarrollMDKitBKLacherDAYoonSS. Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011-2012. NHCS Data Brief (2013) 132:1–8.

  • Google Scholar

• 157

  RodriguezCJDaviglusMLSwettKGonzalezHMGalloLCWassertheil-SmollerSet alDyslipidemia patterns among Hispanics/Latinos of diverse background in the United States. Am J Med (2014) 127:1186–94.10.1016/j.amjmed.2014.07.026

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 158

  Centers for Disease Control and Prevention. Fast Facts and Fact Sheets: Current Cigarette Smoking among Adults in the United States. (2017). Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/

  • Google Scholar

• 159

  KaplanRCBangdiwalaSIBarnhartJMCastañedaSFGellmanMDLeeDJet alSmoking among U.S. Hispanic/Latino adults: the Hispanic Community Health Study/Study of Latinos. Am J Prev Med (2014) 46:496–506.10.1016/j.amepre.2014.01.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 160

  LiaoYTuckerPOkoroCAGilesWHMokdadAHHarrisVBet alREACH 2010 surveillance for health status in minority communities – United States, 2001–2002. MMWR Surveill Summ (2004) 53:1–36.

  • Google Scholar

• 161

  MerchantGBuelnaCCastañedaSFArredondoEMMarshallSJStrizichGet alAccelerometer-measured sedentary time among Hispanic adults: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Prev Med Rep (2015) 2:845–53.10.1016/j.pmedr.2015.09.019

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 162

  Siega-RizAMSotres-AlvarezDAyalaGXGinsbergMHimesJHLiuKet alFood-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic Community Health Study/Study of Latinos. Am J Clin Nutr (2014) 99:1487–98.10.3945/ajcn.113.082685

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 163

  MatteiJSotres-AlvarezDDaviglusMLGalloLCGellmanMHuFBet alDiet quality and its association with cardiometabolic risk factors vary by Hispanic and Latino ethnic background in the Hispanic Community Health Study/Study of Latinos. J Nutr (2016) 146:2035–44.10.3945/jn.116.231209

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 164

  CorsinoLSotres-AlvarezDButeraNMSiega-RizAMPalaciosCPérezCMet alAssociation of the DASH dietary pattern with insulin resistance and diabetes in U.S. Hispanic/Latino adults: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). BMJ Open Diabetes Res Care (2017) 5:e000402.10.1136/bmjdrc-2017-000402

  • CrossRef
  • Google Scholar

• 165

  BermúdezOITuckerKL. Trends in dietary patterns in Latin American populations. Cad Saude Publica (2003) 19(Suppl 1):S87–99.10.1590/S0102-311X2003000700010

  • CrossRef
  • Google Scholar

• 166

  MatteiJMalikVWedickNMHuFBSpiegelmanDWillettWCet alReducing the global burden of type 2 diabetes by improving the quality of staple foods: the global nutrition and epidemiologic transition initiative. Global Health (2015) 11:23.10.1186/s12992-015-0109-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 167

  ZimmetPAlbertiKGShawJ. Global and societal implications of the diabetes epidemic. Nature (2001) 414:782–7.10.1038/414782a

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 168

  Carrera BoadaCAMartínez-MorenoJM. Pathophysiology of diabetes mellitus type 2: beyond the duo “insulin resistance-secretion deficit”. Nutr Hosp (2013) 28(Suppl 2):78–87.10.3305/nh.2013.28.sup2.6717

  • CrossRef
  • Google Scholar

• 169

  DeFronzoRA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes (2009) 58:773–95.10.2337/db09-9028

  • CrossRef
  • Google Scholar

• 170

  HotamisligilGS. Inflammation, metaflammation, and immunometabolic disorders. Nature (2017) 542:177–85.10.1038/nature21363

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 171

  FonsecaFAIzarMC. High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities. Clinics (Sao Paulo) (2016) 71:235–42.10.6061/clinics/2016(04)11

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 172

  SternMPGaskillSPHazudaHPGardnerLIHaffnerSM. Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia (1983) 24:272–7.10.1007/BF00282712

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 173

  EverhartJEPettittDJBennettPHKnowlerWC. Duration of obesity increases the incidence of NIDDM. Diabetes (1992) 41:235–40.10.2337/diabetes.41.2.235

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 174

  JanssenAKatzmarzykPTRossR. Duration of obesity and metabolic health risk in American men and women. Ann Epidemiol (2004) 14:585–91.10.1016/j.annepidem.2004.01.007

  • CrossRef
  • Google Scholar

• 175

  AttardSMHerringAHHowardAGGordon-LarsenP. Longitudinal trajectories of BMI and cardiovascular disease risk: the National Longitudinal Study of Adolescent Health. Obesity (2013) 21:2180–8.10.1002/oby.20569

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 176

  López-VelázquezJASilva-VidalKVPonciano-RodríguezGChávez-TapiaNCArreseMUribeMet alThe prevalence of nonalcoholic fatty liver disease in the Americas. Ann Hepatol (2014) 13:166–78.

  • Pubmed Abstract
  • Google Scholar

• 177

  LazoMBilalUPerez-EscamillaR. Epidemiology of NAFLD and type 2 diabetes: health disparities among persons of Hispanic origin. Curr Diab Rep (2015) 15:116.10.1007/s11892-015-0674-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 178

  LorenzoCHazudaHPHaffnerSM. Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. J Clin Endocrinol Metab (2012) 97:793–9.10.1210/jc.2011-2272

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 179

  HuntKJWilliamsKResendezRGHazudaHPHaffnerSMSternMP. All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the “Hispanic Paradox”. DiabetesCare (2002) 25:1557–63.10.2337/diacare.25.9.1557

  • CrossRef
  • Google Scholar

• 180

  CaballeroAEBousquet-SantosKRobles-OsorioLMontagnaniVSoodiniGPorramatikulSet alOverweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care (2008) 31:576–82.10.2337/dc07-1540

  • CrossRef
  • Google Scholar

• 181

  MendivilCORobles-OsorioLHortonESHamdyOCaballeroAE. Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis. Diabetol MetabSyndr (2013) 5:37.10.1186/1758-5996-5-37

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 182

  FestaAHanleyAJTracyRPD’AgostinoRJrHaffnerSM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation (2003) 108:1822–30.10.1161/01.CIR.0000091339.70120.53

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 183

  HoRCDavyKPHickeyMSMelbyCL. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults. Cytokine (2005) 30:14–21.10.1016/j.cyto.2004.10.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 184

  HuffmanFGGomezGPZariniGG. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans. Ethn Dis (2009) 19:115–20.

  • Pubmed Abstract
  • Google Scholar

• 185

  ReyesMGahaganSDíazEBlancoELeivaLLeraLet alRelationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents. Nutr J (2011) 10:4.10.1186/1475-2891-10-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 186

  McFarlinBKJohnsonCAMorenoJPForeytJP. Mexican American children have differential elevation of metabolic biomarkers proportional to obesity status. J Pediatr Gastroenterol Nutr (2013) 57:718–21.10.1097/MPG.0b013e3182a6993d

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 187

  PérezCMOrtizAPFuentes-MatteiEVelázquez-TorresGSantiagoDGiovannettiKet alHigh prevalence of cardiometabolic risk factors in Hispanic adolescents: correlations with adipocytokines and markers of inflammation. J Immigr Minor Health (2014) 16:865–73.10.1007/s10903-013-9866-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 188

  WeinstockRSDrewsKLCaprioSLeibelNIMcKaySVZeitlerPSet alMetabolic syndrome is common and persistent in youth-onset type 2 diabetes: results from the TODAY clinical trial. Obesity (2015) 23:1357–61.10.1002/oby.21120

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 189

  ParrinelloCMHuaSCarnethonMRGalloLCHudsonBIGoldbergRBet alAssociations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: results from the Hispanic Community Children’s Health Study/Study of Latino Youth (SOL Youth). J Diabetes Complications (2017) 31:836–42.10.1016/j.jdiacomp.2017.01.019

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 190

  KocarnikJMPendergrassSACartyCLPankowJSSchumacherFRChengIet alMultiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet (2014) 7:178–88.10.1161/CIRCGENETICS.113.000173

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 191

  KulickERMoonYPCheungKWilleyJZSaccoRLElkindMS. Racial-ethnic disparities in the association between risk factors and diabetes: the Northern Manhattan Study. Prev Med (2016) 83:31–6.10.1016/j.ypmed.2015.11.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 192

  RosenbaumMFennoyIAccachaSAltshulerLCareyDEHolleranSet alRacial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children. Obesity (2013) 21:2081–90.10.1002/oby.20483

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 193

  Avilés-SantaMLSalinasKHuet-AdamsKRaskinP. Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus. J Investig Med (2006) 54:20–31.10.2310/6650.2005.05012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 194

  MirzaSHossainMMathewsCMartinezPPinoPGayJLet alType 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine (2012) 57:136–42.10.1016/j.cyto.2011.09.029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 195

  KayserBDToledo-CorralCMAldereteTLWeigensbergMJGoranMI. Temporal relationships between adipocytokines and diabetes risk in Hispanic adolescents with obesity. Obesity (2015) 23:1479–85.10.1002/oby.21128

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 196

  PereiraRILow WangCCWolfePHavranekEPLongCSBessesenDH. Associations of adiponectin with adiposity, insulin sensitivity, and diet in young, healthy, Mexican Americans and non-Latino white adults. Int J EnvironRes Public Health (2015) 13:ijerh13010054.10.3390/ijerph13010054

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 197

  HanleyAJBowdenDWagenknechtLEBalasubramanyamALangfeldCSaadMFet alAssociations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab (2007) 92:2665–71.10.1210/jc.2006-2614

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 198

  KoebnickCRobertsCKShaibiGQKellyLALaneCJToledo-CorralCMet alAdiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents. Horm Metab Res (2008) 40:708–12.10.1055/s-2008-1077097

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 199

  HanleyAJWagenknechtLENorrisJMBergmanRAndersonAChenYIet alAdiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care (2011) 34:2231–6.10.2337/dc11-0531

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 200

  GardenerHCrisbyMSjobergCHudsonBGoldbergRMendezAJet alSerum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metab Syndr Relat Disord (2013) 11:46–55.10.1089/met.2012.0065

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 201

  ArslanianSEl GhormliLBachaFCaprioSGolandRHaymondMWet alAdiponectin, insulin sensitivity, β-cell function, and racial/ethnic disparity in treatment failure rates in TODAY. Diabetes Care (2017) 40:85–93.10.2337/dc16-0455

  • CrossRef
  • Google Scholar

• 202

  ButteNFCaiGColeSAWilsonTAFisherJOZakeriIFet alMetabolic and behavioral predictors of weight gain in Hispanic children: the Viva la Familia Study. Am J Clin Nutr (2007) 85:1478–85.

  • Pubmed Abstract
  • Google Scholar

• 203

  MardonesFArnaizPPachecoPDominguezAVillaroelLErikssonJGet alAssociations of prenatal growth with metabolic syndrome, insulin resistance, and nutritional status in Chilean children. Biomed Res Int (2014) 2014:472017.10.1155/2014/472017

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 204

  MonteiroLJNormanJERiceGEIllanesSE. Fetal programming and gestational diabetes mellitus. Placenta (2016) 30:S54–60.10.1016/j.placenta.2015.11.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 205

  KanguruLBezawadaNHusseinJBellJ. The burden of diabetes mellitus during pregnancy in low- and middle-income countries: a systematic review. Glob Health Action (2014) 7:23987.10.3402/gha.v7.23987

  • CrossRef
  • Google Scholar

• 206

  CrumeTLOgdenLDanielsSHammanRFNorrisJMDabeleaD. The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH Study. J Pediatr (2011) 158:941–6.10.1016/j.jpeds.2010.12.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 207

  MooreTR. Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am J Obstet Gynecol (2010) 202:643–9.10.1016/j.ajog.2010.02.059

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 208

  ZhaoPLiuEQiaoYKatzmarzykPTChaputJPFogelholmMet alMaternal gestational diabetes and childhood obesity at age 9-11: results from a multinational study. Diabetologia (2016) 59:2339–48.10.1007/s00125-016-4062-9

  • CrossRef
  • Google Scholar

• 209

  Jiménez-CruzAOrtega-CisnerosABacardí-GascónM. Efecto de la diabetes gestacional sobre los indicadores de adiposidad en los primeros 18 años: Revisión sistemática. Nutr Hosp (2014) 29:397–401.10.3305/nh.2014.29.2.7042

  • CrossRef
  • Google Scholar

• 210

  DavisJNGundersonEPGyllenhammerLEGoranMI. Impact of gestational diabetes mellitus on pubertal changes in adiposity and metabolic profiles in Latino offspring. J Pediatr (2013) 162:741–5.10.1016/j.jpeds.2012.10.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 211

  EgelandGMMeltzerSJ. Following in mother’s footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes. Diabet Med (2010) 27:257–65.10.1111/j.1464-5491.2010.02944.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 212

  PageKARomeroABuchananTAXiangAH. Gestational diabetes mellitus, maternal obesity, and adiposity in offspring. J Pediatr (2014) 164:807–10.10.1016/j.jpeds.2013.11.063

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 213

  SilvermanBLMetzgerBEChoNHLoebCA. Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabetes Care (1995) 18:611–7.10.2337/diacare.18.5.611

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 214

  VaarasmakiMPoutaAElliotPTapanainenPSovioURuokonenAet alAdolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol (2009) 169:1209–15.10.1093/aje/kwp020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 215

  The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med (2008) 358:1991–2002.10.1056/NEJMoa0707943

  • CrossRef
  • Google Scholar

• 216

  MoreliJBCorrêa-SilvaSDamascenoDCSinzatoYKLorenzon-OjeaARBorbelyAUet alChanges in the TNF-alpha/IL-10 ratio in hyperglycemia-associated pregnancies. Diabetes Res Clin Pract (2015) 107:362–9.10.1016/j.diabres.2015.01.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 217

  SobreviaLSalsosoRSáezTSanhuezaCPardoFLeivaA. Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus. Exp Physiol (2015) 100:231–8.10.1113/expphysiol.2014.082743

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 218

  SalomónCWestermeierFPueblaCArroyoPGuzmán-GutiérrezEPardoFet alGestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS One (2012) 7:e40578.10.1371/journal.pone.0040578

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 219

  Hara CdeCFrançaELFagundesDLde QueirozAARudgeMVHonorio-FrançaACet alCharacterization of natural killer cells and cytokines in maternal placenta and fetus of diabetic mothers. J Immunol Res (2016) 2016:7154524.10.1155/2016/7154524

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 220

  GallardoJMGómez-LópezJMedina-BravoPJuárez-SánchezFContreras-RamosAGalicia-EsquivelMet alMaternal obesity increases oxidative stress in the newborn. Obesity (2015) 23:1650–4.10.1002/oby.21159

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 221

  OlmosPRRigottiABussoDBerkowitzLSantosJLBorzoneGRet alMaternal hypertriglyceridemia: a link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity (2014) 22:2156–63.10.1002/oby.20816

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 222

  GelaletiRBDamascenoDCLimaPHSalvadoriDMCalderon IdeMPeraçoliJCet alOxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women. Diabetol Metab Syndr (2015) 7:1.10.1186/1758-5996-7-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 223

  MoreliJBSantosJHLorenzon-OjeaARCorrêa-SilvaSFortunatoRSRochaCRet alHyperglycemia differentially affects maternal and fetal DNA integrity and DNA damage response. Int J Biol Sci (2016) 12:466–77.10.7150/ijbs.12815

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 224

  UwaezuokeSN. Childhood diabetes mellitus and the “double burden of malnutrition”: an emerging public health challenge in developing countries. J Diabetes Metab (2015) 6:1000597.10.4172/2155-6156.1000597

  • CrossRef
  • Google Scholar

• 225

  HalesCNBarkerDJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia (1992) 35:595–601.10.1007/BF00400248

  • CrossRef
  • Google Scholar

• 226

  SilvaAASantosCJAmigoHBarbieriMABustosPBettiolHet alBirth weight, current body mass index, and insulin sensitivity and secretion in young adults in two Latin American populations. Nutr Metab Cardiovasc Dis (2012) 22:533–9.10.1016/j.numecd.2010.09.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 227

  Gonzalez-BarrancoJRios-TorresJMCastillo-MartinezLLopez-AlvarengaJCAguilar-SalinasCABouchardCet alEffect of malnutrition during the first year of life on adult plasma insulin and glucose tolerance. Metabolism (2003) 52:1005–11.10.1016/S0026-0495(03)00151-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 228

  Escaffi FonsecaMJMoreira CarrascoLRodríguez OsiacLPizarro QuevedoTCavada ChacónGVillaroel del PinoLet alEfectos de la desnutrición calórico-proteica temprana en el estado nutricional y atributos del síndrome metabólico en una cohorte de adultos jóvenes. Nutr Hosp (2015) 32:1116–21.10.3305/nh.2015.32.3.9395

  • CrossRef
  • Google Scholar

• 229

  SapunarJBustosPSáezKMuñozSAsenjoS. Efecto del estado nutricional neonatal en el riesgo de síndrome metabólico en niños obesos de 2 comunas de la región del Bío-Bío. Rev Med Chile (2014) 142:1523–9.10.4067/S0034-98872014001200005

  • CrossRef
  • Google Scholar

• 230

  Ramírez-SilvaIRiveraJATrejo-ValdiviaBMartorellRSteinADRomieuIet alBreastfeeding status at age 3 months is associated with adiposity and cardiometabolic markers at age 4 years in Mexican children. J Nutr (2015) 145:1295–302.10.3945/jn.114.198366

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 231

  da Luz SantosCDClementeAPMartinsVJAlbuquerqueMPSawayaAL. Adolescents with mild stunting show alterations in glucose and insulin metabolism. J Nutr Metab (2010) 2010:943070.10.1155/2010/943070

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 232

  EkoéJMShippJ. Malnutrition-related diabetes mellitus: myth or reality. In: EkoéJMZimmetPWilliamsR, editors. The Epidemiology of Diabetes Mellitus: An International Perspective. Chichester, New York: John Wiley (2001). p. 263–72.

  • Google Scholar

• 233

  RaoRH. The role of undernutrition in the pathogenesis of diabetes mellitus. Diabetes Care (1984) 7:595–601.10.2337/diacare.7.6.595

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 234

  ChattopadhyayPSGuptaSKChattopadhyayRKunduPKChakrabortiR. Malnutrition-related diabetes mellitus (MRDM), not diabetes-related malnutrition. Diabetes Care (1995) 18:276–7.10.2337/diacare.18.2.276

  • CrossRef
  • Google Scholar

• 235

  HoetJJTripathyBB. Report of the international workshop on types of diabetes peculiar to the tropics. Diabetes Care (1996) 19:1014.

  • Google Scholar

• 236

  RaoRHYajnikCS. Commentary: time to rethink malnutrition and diabetes in the tropics. Diabetes Care (1996) 19:1014–7.10.2337/diacare.19.9.1014

  • CrossRef
  • Google Scholar

• 237

  LeeCCWatkinsSMLorenzoCWagenknechtLEIl’yasovaDChenYDet alBranched-chain amino acids and insulin metabolism: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care (2016) 39:582–8.10.2337/dc15-2284

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 238

  UmpiérrezGESmileyDKitabchiAE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med (2006) 144:350–7.10.7326/0003-4819-144-5-200603070-00011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 239

  Piñero-PiloñaALitonjuaPAvilés-SantaLRaskinP. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care (2001) 24:1014–8.10.2337/diacare.24.6.1014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 240

  BalasubramanyamANaliniRHampeCSMaldonadoM. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev (2008) 29:292–302.10.1210/er.2007-0026

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 241

  FeresMCFonsecaFAHCintraFDMello-FujitaLde SouzaALDe MartinoMCet alAn assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP. Atherosclerosis (2015) 241:342–9.10.1016/j.atherosclerosis.2015.05.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 242

  CintraFTufikSde PaolaAFeresMCMello-FujitaLOliveiraWet alCardiovascular profile in patients with obstructive sleep apnea. Arq Bras Cardiol (2011) 96:293–9.10.1590/S0066-782X2011005000030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 243

  GrandnerMAChakravortySPerlisMLOliverLGurubhagavatulaI. Habitual sleep duration associated with self-reported and objectively determined cardiometabolic risk factors. Sleep Med (2014) 15:42–50.10.1016/j.sleep.2013.09.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 244

  ShechterA. Obstructive sleep apnea and energy balance regulation: a systematic review. Sleep Med Rev (2016) 34:59–69.10.1016/j.smrv.2016.07.001

  • CrossRef
  • Google Scholar

• 245

  IpMSLamBNgMMLamWKTsangKWLamKS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir CritCare Med (2002) 165:670–6.10.1164/ajrccm.165.5.2103001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 246

  KendzerskaTGershonASHawkerGTomlinsonGLeungRS. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir CritCare Med (2014) 190:218–25.10.1164/rccm.201312-2209OC

  • CrossRef
  • Google Scholar

• 247

  RedlineSSotres-AlvarezDLoredoJHallMPatelSRRamosAet alSleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds: the Hispanic Community Health Study/Study of Latinos. Am JRespir Crit Care Med (2014) 189:335–44.10.1164/rccm.201309-1735OC

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 248

  KnutsonKLWuDPatelSRLoredoJSRedlineSCaiJet alAssociation between sleep timing, obesity, diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort study. Sleep (2017) 40(4):zsx014.10.1093/sleep/zsx014

  • CrossRef
  • Google Scholar

• 249

  CespedesEMDudleyKASotres-AlvarezDZeePCDaviglusMLShahNAet alJoint associations of insomnia and sleep duration with prevalent diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Diabetes (2016) 8:387–97.10.1111/1753-0407.12308

  • CrossRef
  • Google Scholar

• 250

  CadeBEChenHStilpAMGleasonKJSoferTAncoli-IsraelSet alGenetic associations with obstructive sleep apnea traits in Hispanic/Latino Americans. Am J Respir Crit Care Med (2016) 194:886–97.10.1164/rccm.201512-2431OC

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 251

  BakkerJPWengJWangRRedlineSPunjabiNMPatelSR. Associations between obstructive sleep apnea, sleep duration, and abnormal fasting glucose. The multi-ethnic study of atherosclerosis. Am J Respir Crit Care Med (2015) 192:745–53.10.1164/rccm.201502-0366OC

  • CrossRef
  • Google Scholar

• 252

  de la MonteSM. Type 3 diabetes is sporadic Alzheimer’s disease: mini-review. Eur Neuropsychopharmacol (2014) 24:1954–60.10.1016/j.euroneuro.2014.06.008

  • CrossRef
  • Google Scholar

• 253

  SteenETerryBMRiveraEJCannonJLNeelyTRTavaresRet alImpaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease – is this type 3 diabetes?J Alzheimers Dis (2005) 7:63–80.10.3233/JAD-2005-7107

  • CrossRef
  • Google Scholar

• 254

  MayedaERHaanMNKanayaAMYaffeKNuehausJ. Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care (2013) 36:2600–6.10.2337/dc12-2158

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 255

  MayedaERHaanMNYaffeKKanayaAMNeuhausJ. Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans?Alzheimer DisAssoc Disord (2015) 29:206–12.10.1097/WAD.0000000000000083

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 256

  TangWHWKitaiTHazenSL. Gut microbiota in cardiovascular health and disease. Circ Res (2017) 120:1183–96.10.1161/CIRCRESAHA.117.309715

  • CrossRef
  • Google Scholar

• 257

  LambethSMCarsonTLoweJRamarajTLeffJWLuoLet alComposition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes (2015) 2:1–7.10.15436/2376-0949.15.031

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 258

  BrunkwallLOrho-MelanderM. The gut microbiome as a target for prevention and treatment of hyperglycemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia (2017) 60:943–51.10.1007/s00125-017-4278-3

  • CrossRef
  • Google Scholar

• 259

  García-MonzónCVargas-CastrillónJPorreroJLAlonsoMTBonachiaOCastilloMJet alPrevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver Int (2015) 35:1983–91.10.1111/liv.12813

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 260

  MartinEMStybloMFryRC. Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence. Epigenomics (2017) 9:701–10.10.2217/epi-2016-0097

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 261

  Le Magueresse-BattistoniBVidalHNavilleD. Impact of in utero exposure to pollutants on metabolic health in adults. Med Sci (2016) 32:51–6.10.1051/medsci/20163201009

  • CrossRef
  • Google Scholar

• 262

  ChevalierNFenichelP. Bisphenol A: targeting metabolic tissues. Rev EndocrMetab Disord (2015) 16:299–309.10.1007/s11154-016-9333-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 263

  ShearrerGEO’ReillyGABelcherBRDanielsMJGoranMISpruijt-MetzDet alThe impact of sugar sweetened beverage intake on hunger and satiety in minority adolescents. Appetite (2016) 97:43–8.10.1016/j.appet.2015.11.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 264

  BelowJEParraEJ. Genome-wide studies of type 2 diabetes and lipid traits in Hispanics. Curr Diab Rep (2016) 16:41.10.1007/s11892-016-0737-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 265

  LyssenkoVLupiRMarchettiPDel GuerraSOrho-MelanderMAlmgrenPet alMechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest (2007) 117:2155–63.10.1172/JCI30706

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 266

  FlorezJCJablonskiKABayleyNPollinTIde BakkerPIShuldinerARet alTCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med (2006) 355:241–50.10.1056/NEJMoa062418

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 267

  WatanabeRMAllayeeHXiangAHTrigoEHartialaJLawrenceJMet alTranscription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes (2007) 56:1481–5.10.2337/db06-1682

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 268

  Martinez-GomezLECruzMMartinez-NavaGAMadrid-MarinaVParraEGarcia-MenaJet alA replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. Ann Hum Genet (2011) 75:612–20.10.1111/j.1469-1809.2011.00668.x

  • CrossRef
  • Google Scholar

• 269

  PalmerNDLehtinenABLangefeldCDCampbellJKHaffnerSMNorrisJMet alAssociation of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab (2008) 93:304–9.10.1210/jc.2007-1225

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 270

  QiQStilpAMSoferTMoonJYHidalgoBSzpiroAAet alGenetics of type 2 diabetes in U.S. Hispanic/Latino individuals: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes (2017) 66:1419–25.10.2337/db16-1150

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 271

  SousaAGMarquezineGFLemosPAMartinezELopesNHuebWAet alTCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One (2009) 4:e7697.10.1371/journal.pone.0007697

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 272

  MuendleinASaelyCHGeller-RhombergSSondereggerGReinPWinderTet alSingle nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS One (2011) 6:e17978.10.1371/journal.pone.0017978

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 273

  ChoiHJLeeDHJeonHJKimDSLeeYHOhT. Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration. Diabetes Res Clin Pract (2014) 103:e3–6.10.1016/j.diabres.2013.12.051

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 274

  WilliamsALJacobsSBMoreno-MaciasHHuerta-ChagoyaAChurchhouseCMarquez-LunaCet alSequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature (2014) 506:97–101.10.1038/nature12828

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 275

  TraversMEMackayDJDekker NitertMMorrisAPLindgrenCMBerryAet alInsights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes (2013) 62:987–92.10.2337/db12-0819

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 276

  EstradaKAukrustIBjorkhaugLBurttNPMercaderJMGarcia-OrtizHet alAssociation of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA (2014) 311:2305–14.10.1001/jama.2014.6511

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 277

  PalmerNDGoodarziMOLangefeldCDWangNGuoXTaylorKDet alGenetic variants associated with quantitative glucose homeostasis traits translate to type 2 diabetes in Mexican Americans: the GUARDIAN (genetics underlying diabetes in Hispanics) consortium. Diabetes (2015) 64:1853–66.10.2337/db14-0732

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 278

  FrigeriHRMartinsLTAuwerterNCdos Santos-WeissICRPedrosaFOde SouzaEMet alThe polymorphism rs2268574 in glucokinase gene is associated with gestational diabetes mellitus. Clin Biochem (2014) 47:499–500.10.1016/j.clinbiochem.2014.01.024

  • CrossRef
  • Google Scholar

• 279

  JuniorJPFrigeriHRDos Santos-WeissICRegoFGPitchethGAlbertonDet alThe MTNR1B gene polymorphism rs10830963 is associated with gestational diabetes in a Brazilian population. Gene (2015) 568:114–5.10.1016/j.gene.2015.05.024

  • CrossRef
  • Google Scholar

• 280

  BloisSMGueuvoghlanian-SilvaBYTirado-GonzálezITorloniMRFreitagNMattarRet alGetting too sweet: galectin-1 dysregulation in gestational diabetes. Mol Hum Reprod (2014) 20:644–9.10.1093/molehr/gau021

  • CrossRef
  • Google Scholar

• 281

  GelaletiRBDamascenoDCSalvadoriDMMarcondesJPLimaPHMorceliGet alIRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia. Diabetol Metab Syndr (2015) 7:30.10.1186/s13098-015-0026-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 282

  Sánchez MonroyVGonzález DíazALozano TrenadoLMCampos PeraltaJMPolo SotoS. Thr130lle polymorphism of HNF4A gene is associated with gestational diabetes mellitus in Mexican population. J Investig Med (2014) 62:632–4.10.2310/JIM.0000000000000045

  • CrossRef
  • Google Scholar

• 283

  Guzmán-FloresJMEscalanteMSánchez-CoronaJGarcía-ZapiénAGCruz-QuevedoEGMuñoz-ValleJFet alAssociation analysis between -308G/A and -238G/A TNF-alpha gene promoter polymorphisms and insulin resistance in Mexican women with gestational diabetes mellitus. J InvestigMed (2013) 61:265–9.10.2310/JIM.0b013e31827b98c9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 284

  Huerta-ChagoyaAVázquez-CárdenasPMoreno-MacíasHTapia-MaruriLRodríguez-GuillénRLópez-ViteEet alGenetic determinants of gestational diabetes mellitus and related metabolic traits in Mexican women. PLoS One (2015) 10:e0126408.10.1371/journal.pone.0126408

  • CrossRef
  • Google Scholar

• 285

  Reyes-LópezRPérez-LuqueEMalacaraJM. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women. Diabetes Metab Res Rev (2014) 30:701–6.10.1002/dmrr.2538

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 286

  de MeloSFFrigeriHRdos Santos-WeissICRéaRRde SouzaEMAlbertonDet alPolymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes. Biochemistry (2015) 48:1064–7.10.1016/j.clinbiochem.2015.06.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 287

  KulkarniHKosMZNearyJDyerTDKentJWJrGoringHHet alNovel epigenetic determinants of type 2 diabetes in Mexican-American families. Hum Mol Genet (2015) 24:5330–44.10.1093/hmg/ddv232

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 288

  MamtaniMKulkarniHDyerTDGöringHHNearyJLColeSAet alGenome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families. Clin Epigenetics (2016) 8:6.10.1186/s13148-016-0173-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 289

  BarbieiriPNunesJCTorresAGNishimuraRYZuccolottoDCCrivellentiLCet alIndices of dietary fat quality during midpregnancy is associated with gestational diabetes. Nutrition (2016) 32:656–61.10.1016/j.nut.2015.12.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 290

  Ramírez-VélezRBustamanteJCzerniczyniecAAguilar de PlataACLores-ArnaizS. Effect of exercise training on eNOS expression, NO production and oxygen metabolism in human placenta. PLoS One (2013) 8:e80225.10.1371/journal.pone.0080225

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 291

  Ramírez-VélezRAguilar de PlataACEscuderoMMEcheverryIOrtegaJGSalazarBet alInfluence of regular aerobic exercise on endothelium-dependent vasodilation and cardiorespiratory fitness in pregnant women. J Obstet Gynaecol Res (2011) 37:1601–8.10.1111/j.1447-0756.2011.01582.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 292

  Ramírez-VélezR. Aerobic exercise training during pregnancy increases antioxidant status in nulliparous women: secondary data analysis of a controlled clinical trial. Endocrinol Nutr (2013) 60:279–81.10.1016/j.endonu.2012.05.012

  • CrossRef
  • Google Scholar

• 293

  CidMGonzálezM. Potential benefits of physical activity during pregnancy for the reduction of gestational diabetes prevalence and oxidative stress. Early Hum Dev (2016) 94:57–62.10.1016/j.earlhumdev.2016.01.007

  • CrossRef
  • Google Scholar

• 294

  PeralesMSantos-LozanoARuizJRLuciaABarakatR. Benefits of aerobic or resistance training during pregnancy on maternal health and perinatal outcomes: a systematic review. Early Hum Dev (2016) 94:43–8.10.1016/j.earlhumdev.2016.01.004

  • CrossRef
  • Google Scholar

• 295

  Chasan-TaberLSilveiraMMarcusBHBraunBStanekEMarkensonG. Feasibility and efficacy of a physical activity intervention among pregnant women: the Behaviors Affecting Baby and You (B.A.B.Y.) Study. J Phys ActHealth (2011) 8(Suppl 2):S228–38.10.1123/jpah.8.s2.s228

  • CrossRef
  • Google Scholar

• 296

  EhrlichSFHeddersonMMQuesenberryCPJrFengJBrownSDCritesYet alPost-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI study. Diabet Med (2014) 31:862–7.10.1111/dme.12425

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 297

  FerraraAHeddersonMMBrownSDAlbrightCLEnrlichSFTsaiALet alThe comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the gestational diabetes’ effects on moms (GEM) cluster randomized controlled trial. Diabetes Care (2016) 39:65–74.10.2337/dc15-1254

  • CrossRef
  • Google Scholar

• 298

  MendelsonSGMcNeese-SmithDKoniak-GriffinDNyamathiALuMC. A community-based parish nurse intervention program for Mexican American women with gestational diabetes. J Obstet Gynecol Neonatal Nurs (2008) 37:415–25.10.1111/j.1552-6909.2008.00262.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 299

  Philis-TsimikasAFortmannALDharkar-SurberSEuyoqueJARuizMSchultzJet alDulce mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes. Transl Behav Med (2014) 4:18–25.10.1007/s13142-014-0253-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 300

  HawkinsMHoskerMMarcusBHRosalMCBraunBStanekEJet alA pregnancy lifestyle intervention to prevent gestational diabetes risk factors in overweight Hispanic women: a feasibility randomized controlled trial. Diabet Med (2015) 32:108–15.10.1111/dme.12601

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 301

  AthavalePThomasMDelgadillo-DuenasATLeongKNajmabadiAHarlemanEet alLinking high risk postpartum women with a technology enabled health coaching program to reduce diabetes risk and improve wellbeing: program description, case studies, and recommendations for community health coaching programs. J Diabetes Res (2016) 2016:4353956.10.1155/2016/4353956

  • CrossRef
  • Google Scholar

• 302

  Chasan-TaberLMarcusBHRosalMCTuckerKLHartnanSJPekowPet alEstudio Parto: postpartum diabetes prevention program for Hispanic women with abnormal glucose tolerance in pregnancy: a randomized controlled trial – study protocol. BMC Pregnancy Childbirth (2014) 14:100.10.1186/1471-2393-14-100

  • CrossRef
  • Google Scholar

• 303

  HaemerMAGrowHMFernandezCLukasiewiczGJRhodesETShafferLAet alAddressing prediabetes in childhood obesity treatment programs: support from research and current practice. Child Obes (2014) 10:292–303.10.1089/chi.2013.0158

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 304

  BranscumPSharmaM. A systematic analysis of childhood obesity prevention interventions targeting Hispanic children: lessons learned from the previous decade. Obes Rev (2011) 12:e151–8.10.1111/j.1467-789X.2010.00809.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 305

  BrownTSummerbellC. Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: an update to the obesity guidance produced by the National Institute for Health and Clinical Excellence. Obes Rev (2009) 10:110–41.10.1111/j.1467-789X.2008.00515.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 306

  DietzWHGortmakerSL. Preventing obesity in children and adolescents. Annu Rev Public Health (2001) 22:337–53.10.1146/annurev.publhealth.22.1.337

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 307

  LovemanEAl-KhudairyLJohnsonRERobertsonWColquittJLMeadELet alParent-only interventions for childhood overweight or obesity in children aged 5 to 11 years. Cochrane Database Syst Rev (2015) 12:CD012008.10.1002/14651858.CD012008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 308

  Pérez-MoralesMEBacardí-GascónMJiménez-CruzA. Childhood overweight and obesity prevention interventions among Hispanic children in the United States: systematic review. Nutr Hosp (2012) 27:1415–21.10.3305/nh.2012.27.5.5973

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 309

  SticeEShawHMartiCN. A meta-analytic review of obesity prevention programs for children and adolescents: the skinny on interventions that work. Psychol Bull (2006) 132:667–91.10.1037/0033-2909.132.5.667

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 310

  WangYCaiLWuYWilsonRFWestonCFawoleOet alWhat childhood obesity prevention programmes work? A systematic review and meta-analysis. Obes Rev (2015) 16:547–65.10.1111/obr.12277

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 311

  WhitlockEPO’ConnorEAWilliamsSBBeilTLLutzKW. (Oregon Evidence-Based Practice Center, Center for Health Research, Portland, OR). Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents: An Updated, Targeted Systematic Review for the USPSTF. Rockville, MD: Agency for Healthcare Research and Quality (US) (2010). 168 p.

  • Google Scholar

• 312

  WhitlockEPO’ConnorEAWilliamsSBBeilTLLutzKW. Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. Pediatrics (2010) 125:e396–418.10.1542/peds.2009-1955

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 313

  KellyLALaneCJWeigensbergMJToledo-CorralCMGoranMI. Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth. J Pediatr (2011) 158:442–6.10.1016/j.jpeds.2010.08.046

  • CrossRef
  • Google Scholar

• 314

  MarshallWATannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child (1969) 44:291–303.10.1136/adc.44.235.291

  • CrossRef
  • Google Scholar

• 315

  MarshallWATannerJM. Variations in the pattern of pubertal changes in boys. Arch Dis Child (1970) 45:13–23.10.1136/adc.45.239.13

  • CrossRef
  • Google Scholar

• 316

  WellsJCColeTJ. Height, adiposity and hormonal cardiovascular risk markers in childhood: how to partition the associations?Int J Obes (2014) 38:930–5.10.1038/ijo.2014.24

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 317

  YajnikCS. Nutrition, growth, and body size in relation to insulin resistance and type 2 diabetes. Curr Diab Rep (2003) 3:108–14.10.1007/s11892-003-0033-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 318

  BerkowitzRIWaddenTAGehrmanCABishop-GilyardCTMooreRHWombleLGet alMeal replacements in the treatment of adolescent obesity: a randomized controlled trial. Obesity (2011) 19:1193–9.10.1038/oby.2010.288

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 319

  BerkowitzRIWaddenTATershakovecAMCronquistJL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA (2003) 289:1805–12.10.1001/jama.289.14.1805

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 320

  FoxCKKaizerAMRudserKDNathanBMGrossACSunniMet alMeal replacements followed by topiramate for the treatment of adolescent severe obesity: a pilot randomized controlled trial. Obesity (2016) 24:2553–61.10.1002/oby.21633

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 321

  JelalianELloyd-RichardsonEEMehlenbeckRSHartCNFlynn-O’BrienKKaplanJet alBehavioral weight control treatment with supervised exercise or peer-enhanced adventure for overweight adolescents. J Pediatr (2010) 157:923–8.10.1016/j.jpeds.2010.05.047

  • CrossRef
  • Google Scholar

• 322

  Lloyd-RichardsonEEJelalianESatoAFHartCNMehlenbeckRWingRR. Two-year follow-up of an adolescent behavioral weight control intervention. Pediatrics (2012) 130:e281–8.10.1542/peds.2011-3283

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 323

  ParilloMLicenziatiMRVaccaMDe MarcoDIannuzziA. Metabolic changes after a hypocaloric, low-glycemic-index diet in obese children. J Endocrinol Invest (2012) 35:629–33.10.3275/7909

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 324

  ReinehrTKiessWKapellenTAndlerW. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics (2004) 114:1569–73.10.1542/peds.2003-0649-F

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 325

  VenturaEDavisJByrd-WilliamsCAlexanderKMcClainALaneCJet alReduction in risk factors for type 2 diabetes mellitus in response to a low-sugar, high-fiber dietary intervention in overweight Latino adolescents. ArchPediatr Adolesc Med (2009) 163:320–7.10.1001/archpediatrics.2009.11

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 326

  HolubCKElderJPArredondoEMBarqueraSEisenbergCMSánchez RomeroLMet alObesity control in Latin American and U.S. Latinos: a systematic review. Am J Prev Med (2013) 44:529–37.10.1016/j.amepre.2013.01.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 327

  LindbergNMStevensVJ. Review: weight-loss interventions with Hispanic populations. Ethn Dis (2007) 17:397–402.

  • Pubmed Abstract
  • Google Scholar

• 328

  LobeloFGarcia de QuevedoIHolubCKNagleBJArredondoEMBarqueraSet alSchool-based programs aimed at the prevention and treatment of obesity: evidence-based interventions for youth in Latin America. J Sch Health (2013) 83:668–77.10.1111/josh.12080

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 329

  NagleBJHolubCKBarqueraSSánchez-RomeroLMEisenbergCMRivera-DommarcoJAet alInterventions for the treatment of obesity among children and adolescents in Latin America: a systematic review. Salud Publica Mex (2013) 55(Suppl 3):434–40.10.21149/spm.v55s3.5145

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 330

  EisenbergCMSánchez-RomeroLMRivera-DommarcoJAHolubCKArredondoEMElderJPet alInterventions to increase physical activity and healthy eating among overweight and obese children in Mexico. SaludPublica Mex (2013) 55(Suppl 3):441–6.10.21149/spm.v55s3.5146

  • CrossRef
  • Google Scholar

• 331

  AyalaGXIbarraLBinggeli-VallartaAMoodyJMcKenzieTLAnguloJet alOur choice/Nuestra opción: the Imperial County, California, childhood obesity research demonstration study (CA-CORD). Child Obes (2015) 11:37–47.10.1089/chi.2014.0080

  • CrossRef
  • Google Scholar

• 332

  DooyemaCABelayBFoltzJLWilliamsNBlanckHM. The childhood obesity research demonstration project: a comprehensive community approach to reduce childhood obesity. Child Obes (2013) 9:454–9.10.1089/chi.2013.0060

  • CrossRef
  • Google Scholar

• 333

  O’ConnorDPLeeREMehtaPThompsonDBhargavaACarlsonCet alChildhood obesity research demonstration project: cross-site evaluation methods. Child Obes (2015) 11:92–103.10.1089/chi.2014.0061

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 334

  WilliamsNDooyemaCAFoltzJLBelayBBlanckHM. The childhood obesity research demonstration project: a team approach for supporting a multisite, multisector intervention. Child Obes (2015) 1:104–8.10.1089/chi.2014.0063

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 335

  EpsteinLHGordyCCRaynorHABeddomeMKilanowskiCKPaluchR. Increasing fruit and vegetable intake and decreasing fat and sugar intake in families at risk for childhood obesity. Obes Res (2001) 9:171–8.10.1038/oby.2001.18

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 336

  American Diabetes Association. Preventing Type 2 Diabetes [Internet]. Arlington, VA: American Diabetes Association (2014). Available from: http://www.diabetes.org/living-with-diabetes/parents-and-kids/children-and-type-2/preventing-type-2-in-children.html

  • Google Scholar

• 337

  GowMLGarnettSPBaurLAListerNB. The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth. Nutrients (2016) 8:486.10.3390/nu8080486

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 338

  FajcsakZGaborAKovacsVMartosE. The effects of 6-week low glycemic load diet based on low glycemic index foods in overweight/obese children – pilot study. J Am Coll Nutr (2008) 27:12–21.10.1080/07315724.2008.10719670

  • CrossRef
  • Google Scholar

• 339

  GellarLNanselTR. High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance. J Pediatr (2009) 154:455–8.10.1016/j.jpeds.2008.09.040

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 340

  IannuzziALicenziatiMRVaccaMDe MarcoDCinquegranaGLaccettiMet alComparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. Heart Vessels (2009) 24:419–24.10.1007/s00380-008-1138-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 341

  KrebsNFGaoDGrallaJCollinsJSJohnsonSL. Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents. J Pediatr (2010) 157:252–8.10.1016/j.jpeds.2010.02.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 342

  EbbelingCBLeidigMMSinclairKBHangenJPLudwigDS. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med (2003) 157:773–9.10.1001/archpedi.157.8.773

  • CrossRef
  • Google Scholar

• 343

  BouleNGHaddadEKennyGPWellsGASigalRJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA (2001) 286:1218–27.10.1001/jama.286.10.1218

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 344

  BuntJCSalbeADHarperITHansonRLTataranniPA. Weight, adiposity, and physical activity as determinants of an insulin sensitivity index in Pima Indian children. Diabetes Care (2003) 26:2524–30.10.2337/diacare.26.9.2524

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 345

  DuncanGE. The “fit but fat” concept revisited: population-based estimates using NHANES. Int J Behav Nutr Phys Act (2010) 7:47.10.1186/1479-5868-7-47

  • CrossRef
  • Google Scholar

• 346

  LeeSKukJLDavidsonLEHudsonRKilpatrickKGrahamTEet alExercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes. J Appl Physiol (2005) 99:1220–5.10.1152/japplphysiol.00053.2005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 347

  Macias-CervantesMHMalacaraJMGaray-SevillaMEDíaz-CisnerosFJ. Effect of recreational physical activity on insulin levels in Mexican/Hispanic children. Eur J Pediatr (2009) 168:1195–202.10.1007/s00431-008-0907-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 348

  RossRJanssenIDawsonJKunglAMKukJLWongSLet alExercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res (2004) 12:789–98.10.1038/oby.2004.95

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 349

  SugiuraHSugiuraHKajimaKMirbodSMIwataHMatsuokaT. Effects of long-term moderate exercise and increase in number of daily steps on serum lipids in women: randomised controlled trial [ISRCTN21921919]. BMC Womens Health (2002) 2:3.10.1186/1472-6874-2-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 350

  AiresLSilvaGMartinsCMarquesELagoaMJRibeiroJCet alExercise intervention and cardiovascular risk factors in obese children. Comparison between obese youngsters taking part in a physical activity school-based programme with and without individualised diet counselling: the ACORDA project. Ann Hum Biol (2016) 43:183–90.10.3109/03014460.2015.1059889

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 351

  DobbinsMHussonHDeCorbyKLaRoccaRL. School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18. Cochrane Database Syst Rev (2013) 2:CD007651.10.1002/14651858.CD007651.pub2

  • CrossRef
  • Google Scholar

• 352

  JanssenILeblancAG. Systematic review of the health benefits of physical activity and fitness in school-aged children and youth. Int J Behav Nutr Phys Act (2010) 7:40.10.1186/1479-5868-7-40

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 353

  Neumark-SztainerDRFriendSEFlattumCFHannanPJStoryMTBauerKWet alNew moves – preventing weight-related problems in adolescent girls: a group-randomized study. Am J Prev Med (2010) 39:421–32.10.1016/j.amepre.2010.07.017

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 354

  GreyMJaserSSHollMGJeffersonVDziuraJNorthrupV. A multifaceted school-based intervention to reduce risk for type 2 diabetes in at-risk youth. Prev Med (2009) 49:122–8.10.1016/j.ypmed.2009.07.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 355

  TreviñoRPYinZHernandezAHaleDEGarciaOAMobleyC. Impact of the Bienestar school-based diabetes mellitus prevention program on fasting capillary glucose levels: a randomized controlled trial. Arch Pediatr AdolescMed (2004) 158:911–7.10.1001/archpedi.158.9.911

  • CrossRef
  • Google Scholar

• 356

  RosenbaumMNonasCWeilRHorlickMFennoyIVargasIet alSchool-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. J ClinEndocrinol Metab (2007) 92:504–8.10.1210/jc.2006-1516

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 357

  JohnstonCAMorenoJPForeytJP. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Curr Atheroscler Rep (2014) 16:457.10.1007/s11883-014-0457-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 358

  FosterGDLinderBBaranowskiTCooperDMGoldbergLHarrellJSet alA school-based intervention for diabetes risk reduction. N Engl J Med (2010) 363:443–53.10.1056/NEJMoa1001933

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 359

  WilliSMHirstKJagoRBuseJKaufmanFEl GhormliLet alCardiovascular risk factors in multi-ethnic middle school students: the HEALTHY primary prevention trial. Pediatr Obes (2012) 7:230–9.10.1111/j.2047-6310.2011.00042.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 360

  SilvaHJAndersenLBLofrano-PradoMCBarrosMVFreitasIFJrHillJet alImprovements on cardiovascular diseases risk factors in obese adolescents: a randomized exercise intervention study. J Phys Act Health (2015) 12:553–60.10.1123/jpah.2013-0199

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 361

  RyderJRVega-LopezSOrtegaRKonopkenYShaibiGQ. Lifestyle intervention improves lipoprotein particle size and distribution without weight loss in obese Latino adolescents. Pediatr Obes (2013) 8:e59–63.10.1111/j.2047-6310.2013.00162.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 362

  ShaibiGQKonopkenYHoppinEKellerCSOrtegaRCastroFG. Effects of a culturally grounded community-based diabetes prevention program for obese Latino adolescents. Diabetes Educ (2012) 38:504–12.10.1177/0145721712446635

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 363

  Velázquez-LópezLRico RamosJMTorres TamayoMMedina BravoPToca PorrazLEEscobedo de la PeñaJ. Impacto de la educación nutricional sobre alteraciones metabólicas en niños y adolescentes con obesidad. Endocrinol Nutr (2009) 56:441–6.10.1016/S1575-0922(09)73311-X

  • CrossRef
  • Google Scholar

• 364

  KnowlerWCBarrett-ConnorEFowlerSEHammanRFLachinJMWalkerEAet alReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 346:393–403.10.1056/NEJMoa012512

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 365

  RubinRRFujimotoWYMarreroDGBrennemanTCharlestonJBEdelsteinSLet alThe diabetes prevention program: recruitment methods and results. Control Clin Trials (2002) 23:157–71.10.1016/S0197-2456(01)00184-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 366

  WestDSPrewittTEBursacZFelixHC. Weight loss of black, white, and Hispanic men and women in the diabetes prevention program. Obesity (2008) 16:1413–20.10.1038/oby.2008.224

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 367

  O’BrienMJPerezAAlosVAWhitakerRCCiolinoJDMohrDCet alThe feasibility, acceptability, and preliminary effectiveness of a promotora-led diabetes prevention program (PL-DPP) in Latinas: a pilot study. Diabetes Educ (2015) 41:485–94.10.1177/0145721715586576

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 368

  OckeneISTellezTLRosalMCReedGWMordesJMerriamPAet alOutcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino diabetes prevention project. Am J Public Health (2012) 102:336–42.10.2105/AJPH.2011.300357

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 369

  RuggieroLOrosSChoiYK. Community-based translation of the diabetes prevention program’s lifestyle intervention in an underserved Latino population. Diabetes Educ (2011) 37:564–72.10.1177/0145721711411107

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 370

  Van NameMACampAWMagenheimerEALiFDziuraJDMontosaAet alEffective translation of an intensive lifestyle intervention for Hispanic women with prediabetes in a community health center setting. Diabetes Care (2016) 39:525–31.10.2337/dc15-1899

  • CrossRef
  • Google Scholar

• 371

  VincentDMcEwenMMHepworthJTStumpCS. The effects of a community-based, culturally tailored diabetes prevention intervention for high-risk adults of Mexican descent. Diabetes Educ (2014) 40:202–13.10.1177/0145721714521020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 372

  West-PollakAThenEPPodestaCHedeltAPerryMLIzarnoteguiWVet alImpact of a novel community-based lifestyle intervention program on type 2 diabetes and cardiovascular risk in a resource-poor setting in the Dominican Republic. Int Health (2014) 6:118–24.10.1093/inthealth/iht039

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 373

  FainJA. The diabetes prevention program: replicating/translating the results. Diabetes Educ (2009) 35:179.10.1177/01457217090350020301

  • CrossRef
  • Google Scholar

• 374

  GieseKKCookPF. Reducing obesity among employees of a manufacturing plant: translating the diabetes prevention program to the workplace. Workplace Health Saf (2014) 62:136–41.10.3928/21650799-20140305-02

  • CrossRef
  • Google Scholar

• 375

  JacksonL. Translating the diabetes prevention program into practice: a review of community interventions. Diabetes Educ (2009) 35:309–20.10.1177/0145721708330153

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 376

  KrameMKKriskaAMVendittiEMMillerRGBrooksMMBurkeLEet alTranslating the diabetes prevention program: a comprehensive model for prevention training and program delivery. Am J Prev Med (2009) 37:505–11.10.1016/j.amepre.2009.07.020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 377

  SeidelMCPowellROZgiborJCSiminerioLMPiattGA. Translating the diabetes prevention program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care (2008) 31:684–9.10.2337/dc07-1869

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 378

  WhittemorRMelkusGWagnerJDziuraJNorthrupVGreyM. Translating the diabetes prevention program to primary care: a pilot study. Nurs Res (2009) 58:2–12.10.1097/NNR.0b013e31818fcef3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 379

  AliMKEchouffo-TcheuguiJWilliamsonDF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program?Health Aff (2012) 31:67–75.10.1377/hlthaff.2011.1009

  • CrossRef
  • Google Scholar

• 380

  McCurleyJLGutierrezAPGalloLC. Diabetes prevention in U.S. Hispanic adults: a systematic review of culturally tailored interventions. Am J Prev Med (2017) 52:519–29.10.1016/j.amepre.2016.10.028

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 381

  RosasLGLvNXiaoLLewisMAZavellaPKramerMKet alEvaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): a randomized controlled trial. Contemp Clin Trials (2016) 48:30–40.10.1016/j.cct.2016.03.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 382

  Colón-RamosUThompsonFEYarochALMoserRPMcNeelTSDoddKWet alDifferences in fruit and vegetable intake among Hispanic subgroups in California: results from the 2005 California Health Interview Survey. J Am Diet Assoc (2009) 109:1878–85.10.1016/j.jada.2009.08.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 383

  SmithTMColón-RamosUPinardCAYarochAL. Household food insecurity as a determinant of overweight and obesity among low-income Hispanic subgroups: data from the 2011-2012 California Health Interview Survey. Appetite (2016) 97:37–42.10.1016/j.appet.2015.11.009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 384

  HeislerMKaselitzERanaGKPietteJD. Diabetes prevention interventions in Latin American countries: a scoping review. Curr Diab Rep (2016) 16:80.10.1007/s11892-016-0778-7

  • CrossRef
  • Google Scholar

• 385

  SvetkeyLPSimons-MortonDVollmerWMAppelLJConlinPRRyanDHet alEffects of dietary patterns on blood pressure: subgroup analysis of the dietary approaches to stop hypertension (DASH) randomized clinical trial. Arch Intern Med (1999) 159:285–93.10.1001/archinte.159.3.285

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 386

  LimaSTda Silva Nalin de SouzaBFrancaAKSalgado FilhoNSichieriR. Dietary approach to hypertension based on low glycaemic index and principles of DASH (dietary approaches to stop hypertension): a randomised trial in a primary care service. Br J Nutr (2013) 110:1472–9.10.1017/S0007114513000718

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 387

  SartorelliDSSciarraECFrancoLJCardosoMA. Beneficial effects of short-term nutritional counselling at the primary health-care level among Brazilian adults. Public Health Nutr (2005) 8:820–5.10.1079/PHN2005737

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 388

  AssunçãoMCGiganteDPCardosoMASartorelliDSSantosIS. Randomized, controlled trial promotes physical activity and reduces consumption of sweets and sodium among overweight and obese adults. Nutr Res (2010) 30:541–9.10.1016/j.nutres.2010.07.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 389

  LindgärdeFAhrénB. Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of Native American ancestry in Lima, Peru. Diabetes Care (2007) 30:2230–2.10.2337/dc06-2633

  • CrossRef
  • Google Scholar

• 390

  PimentelGDPortero-McLellanKCOliveiraEPSpadaAPOshiiwaMZemdegsJCet alLong-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance. Nutr Res (2010) 30:186–90.10.1016/j.nutres.2010.03.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 391

  BuchananTAXiangAHPetersRKKjosSLMarroquinAGoicoJet alPreservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes (2002) 51:2796–803.10.2337/diabetes.51.9.2796

  • CrossRef
  • Google Scholar

• 392

  XiangAHPetersRKKjosSLMarroquinAGoicoJOchoaCet alEffect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes (2006) 55:517–22.10.2337/diabetes.55.02.06.db05-1066

  • CrossRef
  • Google Scholar

• 393

  BoykoEJGersteinHCMohanVYusufSSheridanPAnandSet alEffects of ethnicity on diabetes incidence and prevention: results of the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial. Diabet Med (2010) 27:1226–32.10.1111/j.1464-5491.2010.03064.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 394

  DeFronzoRATripathyDSchwenkeDCBanerjiMABrayGABuchananTAet alPioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 364:1104–15.10.1056/NEJMoa1010949

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 395

  O’BrienMJPerezAScanlanABAlosVAWhitakerRCFosterGDet alPREVENT-DM comparative effective trial of lifestyle intervention and metformin. Am J Prev Med (2017) 52:788–97.10.1016/j.amepre.2017.01.008

  • CrossRef
  • Google Scholar

• 396

  LewinAJKereiakesDJChrysantSGIzzoJLOparilSLeeJet alTriple-combination treatment with olmesartan medoxomil/amlodipine/hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study. Ethn Dis (2014) 24:41–7.

  • Pubmed Abstract
  • Google Scholar

• 397

  Cooper-DeHoffRMArandaJMGaxiolaECangianoJLGarcia-BarretoDContiRet alBlood pressure control and cardiovascular outcomes in high-risk Hispanic patients – findings from the INternational VErapamil SR/Trandolapril STudy (INVEST). Am Heart J (2006) 151:1072–9.10.1016/j.ahj.2005.05.024

  • CrossRef
  • Google Scholar

• 398

  Cooper-DeHoffRMCohenJDBakrisGLMesserliFHErdineSHewkinACet alPredictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the International Verapamil SR-Trandolapril Study [INVEST]). Am J Cardiol (2006) 98:890–4.10.1016/j.amjcard.2006.04.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 399

  MargolisKLPillerLBFordCEHenriquezMACushmanWCEinhornPTet alBlood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2007) 50:854–61.10.1161/HYPERTENSIONAHA.107.092650

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 400

  WrightJTLacourciereYSamuelRZappeDPurkayasthaDBlackHR. 24-hr ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study. J Clin Hypertens (2010) 12:833–40.10.1111/j.1751-7176.2010.00372.x

  • CrossRef
  • Google Scholar

• 401

  YusufSGersteinHHoogwerfBPogueJBoschJWolffenbuttelBHRet alRamipril and the development of diabetes. JAMA (2001) 286:1882–5.10.1001/jama.286.15.1882

  • CrossRef
  • Google Scholar

• 402

  ElliottWJMeyerPM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet (2007) 369:201–7.10.1016/S0140-6736(07)60108-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 403

  Cooper-DeHoffRMZhouQGaxiolaECangianoJLGarcia-BarretoDHandbergEet alInfluence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST. J Womens Health (2007) 16:632–40.10.1089/jwh.2006.0086

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 404

  PunziHLewinALukicTGoodinTChenW. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial. Ther Adv Cardiovasc Dis (2010) 4:349–57.10.1177/1753944710387629

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 405

  ArandaJMJrCalderonRArandaJMSr. Clinical characteristics and outcomes in hypertensive patients of Hispanic descent. Prev Cardiol (2008) 11:116–20.10.1111/j.1751-7141.2008.08008.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 406

  YiSSTabaeiBPAngellSYRapinABuckMDPaganoWGet alSelf-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record. Circ Cardiovasc Qual Outcomes (2015) 8:138–45.10.1161/CIRCOUTCOMES.114.000950

  • CrossRef
  • Google Scholar

• 407

  PearsonTADenkeMAMcBridePEBattistiWPBradyWEPalmisanoJ. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc (2005) 80:587–95.10.4065/80.5.587

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 408

  AlbertMAGlynnRJFonsecaFAHLorenzattiAJFerdinandKCMacFaydenJGet alRace, ethnicity, and the efficacy of rosuvastatin in primary prevention: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial. Am Heart J (2011) 162:106–14.10.1016/j.ahj.2011.03.032

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 409

  LloretRYcasJSteinMHaffnerSMSTARSHIP Study Group. Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). Am J Cardiol (2006) 98:769–73.10.1016/j.amjcard.2006.04.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 410

  RosenstockJHernandez-TrianaEHandelsmanYMisirSJonesMR. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Postgrad Med (2012) 124:14–20.10.3810/pgm.2012.07.2564

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 411

  GuzmánJRLyraRAguilar-SalinasCACavalcantiSEscañoFTambasiaMet alTreatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Rev PanamSalud Publica (2010) 28:463–71.10.1590/S1020-49892010001200008

  • CrossRef
  • Google Scholar

• 412

  Pan American Health Organization. Diabetes in the Americas [Internet]. Twenty-third Street, N.W (DC) (2016). Available from: http://www2.paho.org/hq/index.php?option=com_content&view=article&id=12126%3Adiabetes-in-the-americas&catid=6648%3Afact-sheets&Itemid=40721&lang=en

  • Google Scholar

• 413

  PopkinBMHawkesC. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol (2016) 4:174–86.10.1016/S2213-8587(15)00419-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 414

  Colón-RamosUMonge-RojasRCamposH. Impact of WHO recommendations to eliminate industrial trans-fatty acids from the food supply in Latin America and the Caribbean. Health Policy Plan (2014) 29:529–41.10.1093/heapol/czt034

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 415

  Argentina, Ministerio de Salud de la Nación [Ministry of Health of the Nation, Argentina]. Iniciativa Menos Sal, Más Vida [Less Salt, More Life Initiative] [Homepage on the Internet]. Buenos Aires, Argentina: Ministerio de Salud, Presidencia de la Nación (2017). Available from: http://www.msal.gob.ar/ent/index.php/informacion-para-ciudadanos/menos-sal--vida

  • Google Scholar

• 416

  Buitrago GonzáezAREscobarNPHernández TorresBCMoreno BarreraCP. Estrategia nacional para la reducción del consumo de sal/sodio en Colombia 2012–2021 [National Strategy for the Reduction of Salt/Sodium Consumption in Colombia 2012–2021]. Bogotá, Colombia: Ministry of Health and Social Protection (2015). 37 p. Spanish. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/SNA/Estrategia-reduccion-sal-2012-2021.pdf

  • Google Scholar

• 417

  NilsonEA. The strides to reduce salt intake in Brazil: have we done enough?Cardiovasc Diagn Ther (2015) 5:243–7.10.3978/j.issn.2223-3652.2015.04.03

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 418

  Pan American Health Organization. Policy Statement: Preventing Cardiovascular Disease in the Americas by Reducing Dietary Salt Intake Population-Wide [Internet]. Twenty Third Street, N.W (DC) (2017). Available from: http://www1.paho.org/hq/dmdocuments/2010/red-salt-policy-statement-eng.pdf

  • Google Scholar

• 419

  ValenzuelaKQuitralVVillanuevaABZavalaFAtalahE. Evaluación del programa piloto de reducción de sal/sodio en el pan en Santiago de Chile. Rev Chil Nutr (2013) 40:119–22.10.4067/S0717-75182013000200004

  • CrossRef
  • Google Scholar

• 420

  GómezLFMosqueraJGómezOLMorenoJPinzónJDJacobyEet alSocial conditions and urban environment associated with participation in the Ciclovía program among adults from Cali, Colombia. Cad Saude Publica (2015) 31(Suppl 1):257–66.10.1590/0102-311X00086814

  • CrossRef
  • Google Scholar

• 421

  GillCVatchevaKPPanJJSmulevitzBMcPhersonDDFallonMet alFrequency of nonalcoholic fatty liver disease and subclinical atherosclerosis among young Mexican Americans. Am J Cardiol (2017) 119:1717–22.10.1016/j.amjcard.2017.03.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 422

  KallwitzERDaviglusMLAllisonMAEmoryKTZhaoLKuniholmMHet alPrevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clin Gastroenterol Hepatol (2015) 13:569–76.10.1016/j.cgh.2014.08.037

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 423

  SzczepaniakLSVictorRGMathurRNelsonMDSzczepaniakEWTyerNet alPancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care (2012) 35:2377–83.10.2337/dc12-0701

  • CrossRef
  • Google Scholar

• 424

  McAuleyPAHsuFCLomanKKCarrJJBudoffMJSzloMet alLiver attenuation, pericardial adipose tissue, obesity, and insulin resistance: the multi-ethnic study of atherosclerosis (MESA). Obesity (2011) 19:1855–60.10.1038/oby.2011.191

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 425

  Troncoso SawyerMDeinesCK. Missing the mark with Latina women with type 2 diabetes: implications for educators. Diabetes Educ (2013) 39:671–8.10.1177/0145721713495716

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 426

  PyatakEAFlorindezDPetersALWeigensbergMJ. “We are all gonna get diabetic these days”: the impact of a living legacy of type 2 diabetes on Hispanic young adults’ diabetes care. Diabetes Educ (2014) 40:648–58.10.1177/0145721714535994

  • CrossRef
  • Google Scholar

• 427

  Scollan-KoliopoulosMWalkerEARappKJ. Self-regulation theory and the multigenerational legacy of diabetes. Diabetes Educ (2011) 37:669–79.10.1177/0145721711416133

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 428

  BuckleyJYektaSJosephVJohnsonHOliverioSDe GrootAS. Vida Sana: a lifestyle intervention for uninsured, predominantly Spanish-speaking immigrants improves metabolic syndrome indicators. J Community Health (2015) 40:116–23.10.1007/s10900-014-9905-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 429

  GutierrezJDeviaCWeissLChantaratTRuddockCLinnellJet alHealth, community, and spirituality: evaluation of a multicultural faith-based diabetes prevention program. Diabetes Educ (2014) 40:214–22.10.1177/0145721714521872

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 430

  ParikhPSimonEPFeiKLookerHGoytiaCHorowitzCR. Results of a pilot diabetes prevention intervention in East Harlem, New York city: project HEED. Am J Public Health (2010) 100(Suppl 1):S232–9.10.2105/AJPH.2009.170910

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 431

  BillimekJSorkinDH. Food insecurity, processes of care, and self-reported medication underuse in patients with type 2 diabetes: results from the California Health Interview Survey. Health Serv Res (2012) 47:2159–68.10.1111/j.1475-6773.2012.01463.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 432

  HaffnerSMSternMPHazudaHPMitchellBDPattersonJK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?JAMA (1990) 263:2893–8.10.1001/jama.263.21.2893

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 433

  PérezCMSoto-SalgadoMSuárezEGuzmánMOrtizAP. High prevalence of diabetes and prediabetes and their coexistence with cardiovascular risk factors in a Hispanic community. J Immigr Minor Health (2015) 17:1002–9.10.1007/s10903-014-0025-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 434

  HandelsmanYBloomgardenZTGrunbergerGUmpierrezGZimmermanRSBaileyTSet alAmerican Association of Clinical Endocrinologists and American College of Endocrinology – clinical practice guidelines for developing a diabetes mellitus comprehensive care plan – 2015. Endocr Pract (2015) 21(Suppl 1):1–87.10.4158/EP15672.GL

  • CrossRef
  • Google Scholar

• 435

  HammanRFHortonEBarrett-ConnorEBrayGAChristophiCACrandallJet alFactors affecting the decline in incidence of diabetes in the diabetes prevention program outcomes study (DPPOS). Diabetes (2015) 64:989–98.10.2337/db14-0333

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 436

  HiverMFJablonskiKAPerreaultLSaxenaRMcAteerJBFranksPWet alUpdated genetic scores based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes (2011) 60:1340–8.10.2337/db10-1119

  • CrossRef
  • Google Scholar

• 437

  ResnicowKBaranowskiTAhluwaliaJSBraithwaiteRL. Cultural sensitivity in public health: defined and demystified. Ethn Dis (1999) 9:10–21.

  • Pubmed Abstract
  • Google Scholar

• 438

  GlazierRHBajcarJKennieNRWillsonK. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care (2006) 29:1675–88.10.2337/dc05-1942

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 439

  AnkerAEFeeleyTHMcCrackenBLagoeCA. Measuring the effectiveness of mass-mediated health campaigns through meta-analysis. J Health Commun (2016) 21:439–56.10.1080/10810730.2015.1095820

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 440

  LindbergNMStevensVJ. Immigration and weight gain: Mexican-American women’s perspectives. J Immigr Minor Health (2011) 13:155–60.10.1007/s10903-009-9298-8

  • CrossRef
  • Google Scholar

• 441

  LindbergNMStevensVJHalperinRO. Weight loss interventions for Hispanic populations: the role of culture. J Obes (2013) 2013:1–6.10.1155/2013/542736

  • CrossRef
  • Google Scholar

• 442

  Chomsky-HigginsKMiclauTAMackechnieMCAguilarDRubio AvilaJBaldy dos ReisFet alBarriers to clinical research in Latin America. FrontPublic Health (2017) 5:57.10.3389/fpubh.2017.00057

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 443

  CardenasMKMirandaJJBeranD. Delivery of type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru. Diabet Med (2016) 33:752–60.10.1111/dme.13099

  • CrossRef
  • Google Scholar

• 444

  OwolabiMMirandaJJYariaJOvbiageleB. Controlling cardiovascular diseases in low and middle-income countries by placing proof in pragmatism. BMJ Glob Health (2016) 1:e000105.10.1136/bmjgh-2016-000105

  • CrossRef
  • Google Scholar